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Abstract 
My graduate research career has focused on studying the principles that underlie 
molecular recognition, which include protein folding, protein-membrane interactions, 
structural preoranization for target binding and non-covalent interactions. This thesis will 
present an overview of this work through three different projects. 
I) Synthetic receptors for target binding in water 
Molecular interactions in water provide the foundation for life. More specifically, 
the interactions between one or more molecules, through hydrogen bonding, π-effects, 
hydrophobic interactions and electrostatic interactions, all play a significant role essential 
to biological processes. This chapter will present an overview of supramolecular 
chemistry in water, with a focus on small molecule receptor “warheads” that target 
biomolecules of interest. The discussion will then move towards the ability to 
preorganize these “warheads” on a scaffold to improve their potency towards a target. 
The fundamental principles discussed in this section will provide a foundation for the 
following chapter in this thesis. 
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II) Understanding Phosphatidylserine Recognition Using the Model cLac Peptide 
The plasma membrane serves as a defining feature of the cell membrane, acting as a 
barrier for material exchange between a cell and its local environment. More importantly, 
membrane lipids are involved in mediating numerous cell-signaling events and acting as 
receptors to recruit proteins that carry out a specific function. Due to the important role 
that lipids play, it is highly desirable to develop affinity ligands for the diverse range of 
lipid headgroup structures on a cell membrane. Although prevalent, proteins have 
intrinsic limitations due to their size, low stabilities and slow clearance rates. This chapter 
will focus on the model peptide, cLac, which was previously developed as an affinity 
ligand for phosphatidylserine recognition.  We will focus on understanding the key 
properties that contribute to PS selectivity and affinity, then attempt to improve this 
scaffold through structural preorganization. 
III) A prolinomycin-based scaffold for developing functional peptides 
Nature has evolved proteins to bind cell-signaling molecules with exquisite 
affinity and specificity, making molecular recognition an essential part of biology. It has 
been a highly sought after goal within the chemistry field to be able to mimic the 
structure and function of certain proteins with smaller molecules, such as peptides. 
Specifically, cyclic peptides are showing promise as therapeutic agents due to their high 
proteolytic stabilities, faster clearance rates and ease of synthesis compared to proteins. 
One challenge, however, is that peptides generally do not possess the ability to properly 
fold and display their side chains for target binding, as proteins do. In this chapter, I will 
present a prolinomycin-based scaffold, which can fold in the presence of K+ ions to 
preorganize its side chains for target binding. Moreover, the focus will be on the 
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structural aspects of this cyclic peptide, along with proof-of-concept studies 
demonstrating its ability to recognize a target under physiological conditions. The 
findings in this study will be useful in developing peptide-based tools that recognize 
various targets. 
 
IV) Dissecting the energetic consequences of fluorinating a protein core 
Proteins have emerged as a powerful class of therapeutic agents due to their superior 
properties over small molecules in the clinic. Some of the key advantages include their 
large surface areas and highly defined structures, which allow them to perform very 
specific functions that are generally not reproducible with traditional small molecule 
scaffolds. In addition, proteins possess the ability to properly fold under physiological 
conditions through precise, noncovalent interactions between their side chain residues. 
Perhaps the most relevant interactions arise from aromatic side chains, which can interact 
in a variety of ways to help proteins fold. In this chapter, we will focus on the model 
protein, VHP35, which contains a hydrophobic core of three interacting Phe residues, to 
study the effects of fluorination on an edge-face interaction.  
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Chapter 1. Synthetic receptors for target binding in water 
 
1.1 Introduction 
Molecular interactions in water provide the foundation for life. More specifically, the 
interactions between one or more molecules, through hydrogen bonding, π-effects, 
hydrophobic interactions, van der Waals forces and electrostatic interactions, play a 
significant role in all essential biological processes. The field of supramolecular 
chemistry embodies these fundamental principles by focusing on systems that incorporate 
weak and reversible non-covalent interactions between two or more chemical entities. 
These types of molecular recognition elements include, but are not limited to, self-
assembly, host-guest complexes and folding, all of which are processes that have inspired 
the synthetic design of functional molecules in water. This chapter will focus on the 
development of synthetic receptors and molecular scaffolds that can exhibit these 
fundamental properties in water.  
The field of supramolecular chemistry in water has rapidly expanded in recent years 
due to the need for developing functional molecules that possess activity in biological 
environments. The main challenges in using water as a reaction medium include 
competition from the bulk solvent, which renders otherwise strong interactions, such as 
hydrogen bonding and polar interactions relatively ineffective. Hydrophobic interactions 
can be used to overcome these drawbacks, but they also present their own unique 
challenges, since solubility and selectivity are generally not optimal under these 
conditions. 
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To overcome these challenges, one must study natural receptors, such as proteins and 
DNA, which complex other functional molecules through several weak, non-covalent 
interactions in water. For example, large, three-dimensional molecules, such as proteins, 
rely on these critical contacts to either maintain their fold, or to selectively recognize a 
binding partner and perform a specific function. These natural systems have inspired the 
rational design of synthetic receptors, which seek to mimic the potent and selective 
binding behaviors of biomolecules that can function through several non-covalent 
interactions in aqueous medium.  
 
1.2 From chemical warheads to synthetic receptors 
 This section presents some key examples of small molecule host receptors that 
can recognize a variety of guest molecules through fundamental molecular interactions, 
which include hydrogen bonding, electrostatic interactions and covalent chemistry. These 
synthetic receptors derive from designed chemical “warheads” that recognize a specific 
functional group that is presented on a biomolecule of interest. In addition to showcasing 
their unique chemical reactivity of the warheads, I will also demonstrate through specific 
examples, how one can take advantage of the cooperative display of these chemical 
“warheads” to gain high specificity and affinity towards a target. The design of such 
receptors will highlight the integration of a range of interactions to successfully target a 
guest molecule. 
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1.2.1 Guanidine-based designs to target carboxylates 
 
Figure 1-1. Interaction between guanidinocarbonylpyrrole receptor with a guest 
carboxylate. Figure adopted from reference [1]. 
In 1999, Schmuck and co-workers introduced a de novo designed carboxylate 
binding motif, which combines electrostatic interactions with multiple hydrogen bonds to 
efficiently target carboxylate motifs [1]. Compared to simple guanidinium cations, which 
can only form stable ion pairs in low dielectric environments, these 
guanidinocarbonylpyrrole receptors contain highly acidic guanidinium species as a result 
of the adjacent acyl group on the scaffold, which in combination with the additional 
hydrogen bonds, help the receptor to form very stable complexes in water (Figure 1-1). 
More specifically, the strong binding to carboxylates in water can be attributed to the 
pyrrole NH group, which acts as a hydrogen bond donor during complexation. To test 
this hypothesis, the binding properties of systematically varied receptors were measured 
by NMR analysis in a 40% water/DMSO mixture to determine association constants (K) 
with N-acetyl alanyl carboxylate (Ac-L-Ala-O-) as the substrate [2]. The structures can be 
found in Figure 1-2. 
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Figure 1-2. Structures of guanidinocarbonylpyrrole receptors with expanded functional 
groups. Figure adopted from reference [2]. 
Compared to a simple guanidinium salt, (K < 10 mol-1), compound 9 exhibits a K 
value of 130 mol-1 in the presence of Ac-L-Ala-O-. Removal of the pyrrole functional 
group affords a simple acylguanidinium cation, which displays a three-fold decreases in 
the K value to 50 mol-1. To further support the benefit of introducing an additional 
hydrogen bond for carboxylate recognition, receptors 10 and 11, which both contain an 
additional amide group adjacent to the pyrrole ring, bind the carboxylate substrate 5 times 
better than 9 at 770 and 690 mol-1, respectively. Interestingly, the best binder was 
receptor 14 (1610 mol-1), which contains a highly branched, isopropyl group that may 
help to induce a favorable receptor conformation. This is supported by the results from 
the more flexible receptor 13, which contains a hydrogen atom in lieu of an isopropyl 
group and displays a weaker association value of 680 mol-1. Collectively, these results 
demonstrate that a simple binding host guest complex, such as that between a 
guanidinium group and a carboxylate group, can be engineered into a more powerful 
N
H
O
H2N
O
NH NH2
NH2
R
N
H
O
HN
O
NH NH2
NH2
H2NOC
R
N
H
O
H2N NH2
NH2
MeOOC
N
H
O
H2N NH2
NH2
O
H2N NH2
NH2
8 9
12
10 R=Et
11 R= Bu
13 R=H
14 R= iPr
	   5	  
complex in water purely through the introduction of carefully placed hydrogen bond 
donors and acceptors. 
 
Figure 1-3. Complex between guanidinocarbonylpyrrole and dipeptide. Figure adopted 
from reference [3]. 
To further validate the utility of this scaffold, the guanidinocarbonylpyrrole 
receptors can be further functionalized to acquire selectivity for a specific target (Figure 
1-3). In this case, the introduction of additional ionizable functional groups helps direct 
the scaffold to target dipeptides in water [3]. Taking advantage of the good association 
constants between the pyrrole group of these receptors and carboxylate groups of amino 
acids, additional hydrogen bond donors from the receptor amide and imidazole groups 
can further stabilize the peptide backbone, affording association constants between 
15,900-54,300 mol-1 depending on the dipeptide sequence. The values for dipeptides 
were nearly 10-fold better than for simple amino acids, indicating that these receptors can 
be further engineered through the simple addition of hydrogen bonds to target a variety of 
substrates. 
Moving forward with guanidinium-based receptors, Kilburn and co-workers 
designed an efficient, high-throughput method to identify stereoselective receptors for 
peptides in water based on an N,N’-dipeptide-substituted guanidinium receptor [4]. 
Utilizing a “tweezer” scaffold, which incorporates a guanidinium group for site-specific 
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detection of a peptide C-terminus and two peptidic arms, they were able to screen a 
library of guanidinium containing receptors on resin using dye-labeled peptide guests in 
aqueous media. 
 
Figure 1-4. Synthesis of asymmetric tweezer library. Figure adopted from reference [5]. 
The limitation of this approach is in the lack of chemical diversity. Since both 
peptidic arms must be synthesized simultaneously, the receptors contain two identical 
sequences. To circumvent this issue, Kilburn and co-workers have developed an 
orthogonal approach to synthesize chemically diverse guanidinium-containing receptors 
(Figure 1-4) [5]. The guanidinium receptor was functionalized on a solid support, 
followed by Fmoc-deprotection of the first guanidyl residue, then split-and-mix synthesis 
to form the first peptidic arm. Removal of a Dppe-protecting group on the second arm, 
followed by another split-and-mix synthesis yielded chemically diverse, asymmetric 
receptor libraries. Using this method, they were able to identify a potent and 
stereoselective receptor with an estimated association constant of 1350 mol-1 for the 
substrate N-Ac-Lys-D-Ala-D-Ala, versus 250 mol-1 for N-Ac-Lys-L-Ala-L-Ala.  
The examples listed above demonstrate how a simple receptor, such as 
guanidinium, can be transformed to exhibit powerful host-guest complexation properties 
in a highly competitive media, such as water.  
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1.2.2 Squaramides: A versatile and neutral warhead 
Squaramides are a unique class of four-membered ring systems that can participate in 
up to four hydrogen bonds at a time in water. The high affinity for H-bonding is a result 
of the delocalization of electrons upon target binding, which in turn, enhances the 
aromaticity of the squaramide. In addition to these properties, the squaramide is a planar 
molecule, which helps to provide structural rigidity, while the precursor, squarate ester, 
allows the molecule to be easily functionalized via a number of synthetic methods [6]. 
Due to the versatility of this molecule in aqueous systems, it can act as a powerful host 
receptor to bind a number of diverse and biologically relevant targets.  
A given aqueous solution contains many counter-ion complexes that can compete 
with a charged host molecule for target binding. Additionally, the non-directional nature 
of charged receptors makes them more promiscuous binders in water, leading to 
undesired off-target effects. In combination with its other properties, the neutrality of a 
squaramide allows it to bind guest molecules with high affinity and selectivity in water.  
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Figure 1-5. Squaramide H-bonding increases ring aromaticity. Figure adopted from 
reference [6]. 
Several studies have been conducted in which the anion binding properties of 
squaramides were assessed [7, 8]. Work by Quinonero and co-workers demonstrated the 
superiority of squaramides as H-bond donors over other neutral molecules, such as ureas 
[9]. Upon complexation with either a cation or an anion, the four-membered ring of the 
squaramide becomes more aromatic, allowing it to act as a bifunctional motif.  
Researchers referred to nucleus independent chemical shift (NICS) values to study the 
variable anion binding ability of squaramides, where a more negative NICS value denotes 
a more aromatic structure (Figure 1-5). The results demonstrate that the squaramide-
anion complex (-7.6) is more aromatic than just the squaramide alone (-6.3), which 
explains the enhanced hydrogen bond donor character. If at the same time an ammonium 
carboxylate
carboxylate
ammonium
ammonium
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ion complexes the carbonyl oxygens of the squaramide, the entire complex (-8.7) 
becomes even more aromatic, denoting the potential for designing a multi-functional 
“warhead” that can for two simultaneous interactions with a target. 
 
Figure 1-6. Hydrogen bonding donor-acceptor ability of squaramides versus ureas. 
Figure adopted from reference [6]. 
From a structural standpoint, the squaramide demonstrates excellent superiority 
towards guest molecules over other receptors, such as urea, due to the presence of two 
carbonyl oxygens, which helps it to form stronger acceptor interactions (Figure 1-6). 
Collectively, these favorable properties make squaramides a great candidate for 
developing artificial receptors of natural biomolecules and following examples will 
demonstrate the utility of this warhead towards target recognition.  
 
squaramide urea
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Figure 1-7. Structures of squaramide, thiourea and urea-based fluorinated molecules. 
Figure adopted from reference [11]. 
Diseases, such as cystic fibrosis, have triggered an active interest in developing 
drugs that can transport anions across lipid bilayers. These diseases are usually triggered 
by a malfunction in the ability of a transmembrane ion channel to regulate the flow of 
ions such as chloride and carbonate, across a membrane [10]. Therefore, the development 
of a receptor that can recognize and transport ions across a lipid bilayer, thus restoring 
their permeability, are of high interest in the biomedical field. Gale and co-workers 
reported the use of fluorinated squaramide-based receptors to bind and transport anions 
across a lipid bilayer [11].  
Squaramides not only exhibit superior hydrogen bonding capabilities, but they are 
stable to nucleophilic attack under physiological conditions, which helps to reduce its 
toxicity, making it a superior drug candidate. Focusing on a carefully designed library of 
squaramide thiourea urea
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molecules (Figure 1-7), they found that squaramide receptors 1, 4 and 7 (Ka values of 
260, 458 and 643 mol-1, respectively) transported chloride anions nearly 1 order of 
magnitude better than the urea and thiourea counterparts, with the highly fluorinated 
compounds exhibiting the best transport properties. Enhanced fluorination on the urea 
and thiourea scaffolds did not significantly enhance the transport properties, indicating 
that fluorination had a better electronic effect on the squaramide scaffold. Additionally, 
several studies have shown that squaramide-based compounds are less lipophilic than 
their urea and thiourea counterparts [12, 13], demonstrating that the transport properties 
are not simply a result of the hydrophobic nature of the receptor, but rather due to the 
inherent increase in aromatization upon anion binding. 
 
Figure 1-8. Synthesis of squaramide-based amino acids. Figure adopted from reference 
[14]. 
Joliffe and co-workers developed a library of squaramide-based amino acid 
receptors to study the anion complexation properties of squaramide-based amino acids 
(Figure 1-8) using 1H NMR spectroscopy [14]. Any interaction between the squaramide 
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and anion can be characterized by signature downfield shifts, or the disappearance of 
amide resonances. Interestingly, a general trend was observed for receptors 1-3, where 
the squaramide containing the most electron withdrawing properties (3) bound Cl- the 
strongest (Ka = 383 M-1), followed by 2 (Ka = 209 M-1) and then 1 (Ka = 180 M-1). 
Further investigation revealed that receptor 1 selectively binds SO42- anions, Ka>104 M-1, 
which may be a result of hydrogen bonding from both the squaramide and the amide NH 
moieties. Tuning the lipophilicity on either the N or C-terminus of the squaramide-based 
amino acid receptors had negligible impact on anion binding affinity, indicating that 
these scaffolds possess functional group tolerance and can be incorporated into larger 
peptide sequences without losing their intrinsic anion recognition properties. 
The previous example demonstrates the ability to target a wide variety of anions 
in polar solvents by simply tuning the electronic properties of a synthetically designed 
squaramide-based receptor. The following example will demonstrate how this “warhead” 
molecule can be further functionalized to acquire selectivity for a specific anion through 
its pre-organized, multivalent display on a molecular scaffold.  
Sulfate plays an important role in biology and selective targeting of this inorganic 
ion can yield many applications within the biomedical field. Not only does sulfate play an 
essential role in the formation of proteins in mucin [15] and in joints [16], low levels can 
be found in patients with rheumatoid arthiritis and irritable bowel disease, making it a 
prime target for diagnostic applications. The obvious challenge arises in targeting this ion 
in a highly competitive aqueous media, and oftentimes the incorporation of additional 
charged groups to sulfate recognition motifs is necessary to overcome the desolvation 
penalty. However, additional charged residues can compromise the selectivity and 
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enhance the toxicity, making it an undesirable approach to develop clinical candidates 
[17]. Nature has developed elegant receptors, such as the sulfate binding protein (SBP), 
to bind sulfate through a carefully placed network of hydrogen bonds [18]. Using a 
similar strategy to preorganize a receptor for binding, Joliffe and co-workers reporter a 
novel class of macrocyclic squaramide-containing receptors (MSQ’s) to specifically 
target sulfate ions (Figure 1-9) [19]. 
 
Figure 1-9. Structures of macrocyclic squaramide-containing receptors, showing various 
ring sizes. Figure adopted from reference [19]. 
  The addition of SO42- or H2PO4- to [2]-MSQ 1 in DMSO (0.5% H2O) caused a 
distinct change in the 1H NMR spectrum where the signals corresponding to the amide 
NHs, as well as the aromatic proton that sits between the two ring substituents, shifted 
downfield. Interestingly, upon the addition of one equivalent of SO42-, the benzylic 
protons transformed from a broad peak to two very sharp peaks signals, indicating the 
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presence of two protons in inequivalent environments. The H2PO4- did not elicit a similar 
response, indicating that [2]-MSQ 1 can fully complex the SO42- ion to afford a rigid, 
single macrocyclic conformer in solution. [3]-MSQ-2, which is a larger macrocycle, also 
exhibits these characteristic signatures in the 1H NMR spectrum, but never fully collapses 
into a single conformer.  
 To investigate the activities of MSQ-1 and MSQ-2 in a more relevant, aqueous 
environment, water-soluble triethylene glycol derivatives of MSQ-5 and MSQ-6 were 
prepared and studied. Interestingly, MSQ-6 displayed remarkable selectivity for SO42- 
anions in the presence of other tetrahedral anions with a Ka value of >104 mol-1. 
Molecular modeling revealed that the high binding affinity for a sulfate ion might be a 
result of the optimal size of the binding cavity, which in conjunction with the additional 
squaramide binding site and C-H hydrogen bonding motifs, can complex the anion 
efficiently. Although the NMR signatures indicated a well-defined structure in the 
presence of the anion, the crystal structure of the MSQ-1 sulfate complex showed that the 
binding cavity is too small, leaving the sulfate anion sitting on top of the cavity, solvent 
exposed. 
 This piece of work demonstrates how a known small molecule anion receptor, 
such as a squaramide, can be further functionalized to develop larger, more refined host 
complexes that exhibit superb selectivity’s in highly polar, aqueous media. 
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1.2.3 Boronic acid receptors: covalent targeting of diols   
 
Figure 1-10. Diol-mediated boronate ester formation. Figure adopted from reference 
[20]. 
Aromatic boronic acids can reversibly interact with a variety of diols to form 
boronate esters under physiologically relevant conditions (Figure 1-10) [20]. These 
chemical motifs have been used to target functional groups such as 1,2- and 1,3- diols on 
saccharides [21, 22], as well as carbohydrates [23, 24] and glycoproteins [25]. Much like 
the other host receptors presented earlier in this chapter, boronic acid structures are 
amenable to structural modifications and their properties can be tuned to bind and 
recognize a specific target. Collectively, these properties make boronic acids attractive 
candidates in the development of recognition motifs for a wide variety of biologically 
relevant targets. 
One of the major drawbacks in drug design is the difficulty in delivering the 
therapeutic agent to its target [26]. Some methods have been developed to overcome this 
issue, which include the use of natural ligands, such as the RGD peptide, and folic acid, 
to enhance the association of a chemotherapeutic agent with its cellular target [27]. Other 
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methods include the use of cationic peptides, such as nonarginine and HIV-TAT to 
accomplish the association with anionic cell surfaces [28].  
Raines and co-workers have demonstrated through a series of work, how boronic 
acid-containing compounds can mediate the delivery of a protein into the cytosol of a 
mammalian cell [29]. Similar to the case of lectin conjugates [30], they sought to develop 
boronic acid-containing compounds that could selectively target glycocalyx, which is a 
cell surface polysaccharide [31], to mediate the delivery of therapeutic agents into the 
cell. Using bovine pancreatic ribonuclease (RNase A), which is an enzyme that promotes 
cell death in the cytosol [32, 33], they could assess whether the boronic acid-containing 
moiety and would be effective in drug delivery by monitoring the cell death. 
 
Figure 1-11. Benzoxaborole-mediated cargo delivery into cells. Figure adopted from 
reference [29]. 
Quantification of simple boronic acids with various diols revealed a particular 
affinity towards sialic acid, which is abundant in the glycolax of cancer cells [34], 
indicating that these receptors could potentially direct therapeutic agents to the site of 
tumors.  Moving forward with 2-Hydroxymethylphenylboronic acid (benzoxaborole), 
which has the highest reported interaction with pyranose saccharides, also abundant in 
the glycolax, they conjugated this moiety on to RNase A and observed 4-5 fold enhanced 
uptake of this complex into the cell versus the unmodified form (Figure 1-11). 
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Specifically, boron-saccharide complexation was confirmed by the addition of fructose, 
which competes away this interaction. More importantly, boronated RNase A inhibited 
the proliferation of human erythroleukemia cells, while the chemically inactivated 
complex was less cytotoxic, indicating that the boronate moiety helps facilitate cellular 
uptake, as well as enhances the delivery of cargo into the cytosol. Although this example 
demonstrates the utility of a boronic acid-based receptor to target cell surface diols for 
potential drug delivery applications, it is still unclear as to how the selectivity will be 
maintained in a complex, in vivo environment. 
To acquire this desired selectivity, one must take advantage of the other unique 
functional groups that may be present on a guest molecule. Moving beyond host-guest 
complex formation of boronic acids with cell surface diols, we turn to other biologically 
relevant guest molecules, such as neurotransmitters. Catecholamines, such as dopamine, 
are a major class of neurotransmitters and their malfunction in central nervous system 
and can have negative implications in neurological diseases [35]. There has been much 
interest in developing specific receptors for dopamine to study its role in disease and 
many recognition elements have been developed to function in an aqueous environment. 
Among them include the use of RNA aptamers [36], as well as membrane-association 
receptors [37].  
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Figure 1-12. Selective recognition of catcheolamines via boronic acid-mediate imine 
formation. Figure adopted from reference [38]. 
Glass and co-workers reported in the development of a small molecule, boronic 
acid-based coumarin receptor to target and sense catechols under physiological 
conditions [38]. The aldehyde-containing scaffold exhibits an intrinsic affinity for 
amines; however, little selectivity is observed between various guest amines. To 
circumvent this problem, they installed a boronic acid to act as an additional recognition 
motif for the catechol group (Figure 1-12). Interestingly, the receptor bound dopamine, 
norepinephrine and epinephrine with similar association constants of 3400, 6500 and 
5000 mol-1, respectively. The lack of a primary amine on epinephrine indicates that the 
boronic acid-diol complex is a more significant driving force for complex formation than 
imine formation. As a colorimetric sensor, the compound demonstrated superb selectivity 
for dopamine and norepinephrine in the presence of other guest ligands. This example 
illustrates how the cooperative nature of several “warheads” can yield potent and 
selective receptors for biomolecules of interest. 
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1.3 Scaffolds 
Thus far, we have discussed the properties of a variety of small molecule, synthetic 
receptors that can target a wide variety of guest molecules in an aqueous environment. 
Host-guest complexation proceeds through the intrinsic chemical functionality of the 
receptor, which helps to bind a target with high affinity and selectivity. Although some 
examples attempted to provide a structural basis for their recognition properties, the 
molecules were not designed to preorganize the chemical functionalities for binding. 
Nature has elegantly evolved a diverse class of macromolecular receptors that adopt 
structurally preogranized conformations in water. The underlying cause of 
preorganization is the result of molecular interactions that occur either within the scaffold 
itself, or in the presence of a guest, such as a metal ion. The following examples provide 
an overview of the critical molecular recognition elements involved in the design of 
potent scaffolds with biological activity.  
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1.3.1 Vancomycin
 
Figure 1-13. Vancomycin and D-Ala-D-Ala complex. Figure adopted from reference 
[39]. 
Vancomycin is a glycopeptide antibiotic that is generally used as a last line of 
defense against Gram-positive strains of bacteria, such as Staphylococcus aureus, which 
has developed highly resistant strains. It selectively recognizes the Ac-D-Ala-D-Ala 
terminus of the peptidoglycan component of the bacterial cell wall through a series of 
five, carefully preorganized, hydrogen bonds from its peptide backbone (Figure 1-13) 
[39]. Extensive structural studies were carried out to determine that vancomycin adopts a 
dimeric conformation in solution, providing two binding pockets into which the branched 
D-Ala-D-Ala side chains of the peptidoglycan wall can dock. This conformational 
analysis suggests that vancomycin inserts itself between different glycopeptide strands, 
thereby preventing their efficient crosslinking in the cell wall [40]. Although vancomycin 
5 H-Bonds
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can selectively target these components of the cell wall, resistant strains of bacteria have 
emerged, in which an isosteric replacement of the D-Ala to a D-Lactate renders a 
hydrogen bonding interaction between the host-guest complex inert.
 
Figure 1-14. Intracellular delivery of vancomycin through native host-guest complex. 
Figure adopted from reference [41]. 
Additional drawbacks associated with highly polar glycopeptide antibiotics, such 
as vancomycin, include their low cell permeability, which renders them ineffective 
towards bacterial pathogens that are capable of replicating in mammalian host cells or in 
organs that are protected by a membrane barrier, such as the brain. Peterson and co-
workers developed a receptor-mediated delivery strategy to circumvent this problem and 
to promote the efficacy of this drug in more difficult to access targets [41]. They used a 
synthetic derivative of the natural vancomycin ligand, called D-Phe-D-Ala, linked to a 
cholesterol-derived membrane anchor, in order to access the membrane trafficking 
pathway (Figure 1-14). Upon incorporation of the D-Phe-D-Ala-cholesterol complex into 
the mammalian cell membrane, vancomycin selectively targets this receptor, and 
becomes incorporated into endosomes where it is either degraded, or escapes into the 
cytoplasm to access the host-infected pathogens. Interestingly, the ability of D-Phe-D-Ala 
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to deliver vancomycin into HeLa cells infected by L. monocytogenes proved to be 
successful, while the isosteric L-Phe-L-Ala analogue was inert. Although resistant strains 
of bacteria have emerged against vancomycin, rendering it inert in certain cases, this 
work demonstrates how the molecular recognition properties of the antibiotic host-guest 
complex can be exploited to develop novel methods of drug delivery. 
1.3.2 Lantibiotics (cinnamycin and duramycin) 
 
Figure 1-15. Structure and sequence of cinnamycin exhibiting high degree of 
crosslinking. Figure adopted from reference [42]. 
Cinnamycin is a highly crosslinked, tetracyclic peptide antibiotic that selectively 
targets phosphatidylethanolamine (PE) with nanomolar affinity on bacterial cell 
membranes. This 19 amino acid long sequence contains one lanthionine (Lan), two 
methyllanthionine (MeLan), and a lysinoalanine (Lal) crosslink, which help the peptide 
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adopt its rigid conformation [42]. In addition, cinnamycin contains an erythro-3-hydroxy-
L-aspartic acid, which results from the hydroxylation of L-Asp at position 15. This 
critical residue is responsible for the peptides selective interaction with the ammonium 
functional group of PE (Figure 1-15). The well-established interaction between this 
peptide and PE makes is an ideal candidate for studying membrane interactions.               
Its structural analogue, duramycin, differs only in that it contains a Lys instead of an 
Arg residue within its sequence, but both peptides exhibit considerable cytotoxicity at 
low micromolar concentrations in mammalian cells, which complicate the ability to study 
membranes. Zhao and co-workers recently reported the development of a molecular 
probe based on duramycin, which attaches a green fluorescent protein (GFP) to the C-
terminus of duramycin using a PEG linker and found that it induced little cytotoxicity, 
while still retaining its PE specificity [43] . Cell imaging studies revealed that PE remains 
sequestered in the inner leaflet of the plasma membrane, while in apoptotic cells the 
asymmetric distribution is lost. Previous work using biotinylated cinnamycin and FITC-
conjugated streptavidin demonstrated that the phospholipid membrane at the apical area 
of sperm becomes more fluid during fertilization, which results in the translocation of PE 
and PS occurs to the outer leaflet. GFP-duramycin also yielded consistent results, 
demonstrating how this novel probe can be used to study the kinetics of membrane 
reorganization in reproductive biology.  
The ability to use lower concentrations of duramycin helps to elucidate more 
mechanistic insights into the peptide-membrane interaction. Using artificial membranes, 
they were able to show that low micromolar concentrations of duramycin can destabilize 
membranes and induce vesicle fusion in the presence of PE, suggesting that peptide-
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membrane interaction is required to induce cytotoxic effects. Overall, this study 
demonstrates how a highly structured receptor, such as cinnamycin or duramycin, can be 
used as an efficient imaging probe to study the mechanisms of PE in the cell membrane. 
This powerful host-guest complex can be further implemented in more biologically 
relevant conditions to further understand the interaction between antibiotics and cell 
membranes.  
1.3.3 Cucurbit[n]uril  
The previous examples illustrate how nature has elegantly designed natural receptors 
to bind a specific target through the structural preorganization of otherwise simple amino 
acids. From a purely synthetic standpoint, these structures are quite difficult to access, but 
the following example attempts to demonstrate the potential of designing preorganized 
receptors for target binding.  
 
Figure 1-16. Stuctures of cucurbut[n]uril derivatives. Figure adopted from reference 
[47]. 
Increasing cavity size
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Cucurbit[n]urils are macrocyclic compounds made up of glycoluril monomers that are 
linked through methylene groups, where n denotes the number of glycoluril units (Figure 
1-16). Although first synthesized in 1905 by Behrand [44], the structure was not 
elucidated until 1981 [45, 46] and since then, cucurbiturils possessing 5, 6, 7, 8, 10 and 
14 repeating units have all been isolated[46, 47]. The carbonyl oxygens that line the rim 
of the cavity point slightly inward and promote a unique architecture for molecular 
recognition of cationic or neutral species. Additionally, the molecular recognition 
properties can be fine-tuned with the size of the cavity, allowing it to encapsulate guest 
molecules of various sizes [47]. For example, cucurbit[5]uril, can selectively encapsulate 
Pb2+ over other metals, such as NH4+ and other alkali and alkali-earth cations (>105.5) 
[48], while its slightly larger counterpart, cucurit[6]uril, can form stable complexes with 
more diverse guests, such as, diaminoalkanes. In the latter case, the inclusion of a non-
polar methylene unit within the host cavity is the result of a hydrophobic effect, which 
seeks the release of “high-entropy” water to accommodate this guest molecule.   
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Figure 1-17. Cucurbit[7]uril and clofazimine structures. Figure adopted from reference 
[49]. 
Cucurbit[7]uril is perhaps the most applicable scaffold in drug design due its superior 
water solubility, as well as the unique size of its cavity, which can accommodate larger 
guest molecules, such as drugs. Wang and co-workers recently investigated the ability of 
cucurbit[7]uril (CB7) to encapsulate a model anti-tuberculosis drug, clofazimine (CFZ), 
which exhibits poor water solubility and high lipophilicity, lending to its poor 
bioavailability (Figure 1-17) [49]. In this study, researchers studied its influence on CFZ 
solubility, cardiotoxicity and antimyobacterial activity. Although CFZ exhibits poor 
water solubility, using 1H NMR spectroscopy, they were able to observe the host-guest 
protons upon the gradual addition of CB7 to the solution, indicating that CFZ becomes 
solubilized in the presence of this scaffold. Further, a phase solubility diagram exhibited 
a linear increase in guest solubility upon addition of a host, indicating a 1:1 binding mode 
between the complex.  
Carrier Drug
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To analyze the efficacy of CB7 on cardio toxicity in vivo, researchers incubated a 
transgenic zebrafish model with toxic concentrations of CFZ and observed cardiac 
functions. Upon the addition of CB7, cardiac functions were significantly improved, 
while the CB7 alone control displayed negligible effects. Additionally, CB7 had little 
effect on the antimycobacterial activity of CFZ in vitro, as demonstrated by a minimal 
inhibitory concentration (MIC) assay, indicating that drug efficacy is well preserved in 
the presence of this scaffold. Overall, this study exemplifies how one can take advantage 
of the host properties of a well-defined scaffold to bind and solubilize a lipophilic drug, 
thereby enhancing its bioavailability. 
1.3 Conclusion 
In summary, the examples above demonstrate how the development of 
supramolecular chemistry relies on advances in receptor selectivity for the chemical 
recognition of a guest molecule, as well as the structural preorganization to display these 
“warheads” for target recognition. In the following chapters, I will attempt to illustrate 
these concepts through several projects. Chapter 2 will focus on a detailed mechanistic 
investigation of the cyclic peptide scaffold, cLac, towards phosphatidylserine (PS) 
recognition. In this work, we seek to understand the specific contribution of each receptor 
functional group towards target recognition and attempt to design a structural analogue 
that can better preorganize them for target binding. Chapter 3 moves further into the 
structural preorganization aspect, where we introduce a novel, prolinomycin-based 
scaffold that can fold in the presence of a monovalent cation to preorganize its side 
chains for target binding. Finally, chapter 4 focuses on the more fundamental aspects of 
molecular recognition, where we investigate the contribution of fluoroaromatics towards 
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enhancing or destabilizing a protein fold using the model protein, villin headpiece, 
VHP35.  
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Chapter 2. Understanding Phosphatidylserine Recognition Using the Model cLac 
Peptide 
 
2.1 Introduction 
 The plasma membrane serves as a defining feature of a living cell, acting as a 
barrier for material exchange between a cell and its local environment. More importantly, 
membrane lipids are involved in mediating numerous cell-signaling events, playing 
active roles as receptors to recruit relevant proteins for cellular processes [50]. Mass 
spectrometry analysis of the lipidome suggests that there are over 1000 distinct lipid 
molecules on a mammalian cell membrane [51]. Combined with the important roles that 
they play, it is highly desirable to develop affinity ligands for the diverse range of lipids 
headgroups on a membrane.  
 
2.1.1 Phosphatidylserine exposure during apoptosis 
 
Figure 2-1. Asymmetric distribution of phospholipids on a mammalian cell membrane. 
Figure adopted from reference [52]. 
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The normal distribution of phospholipids on a cell membrane is asymmetrical. 
The choline containing lipids, such as phosphatidylcholine (PC) and sphingomyelin (SM) 
make up the bulk of the matrix and are present on the outer face of the membrane, while 
the aminophospholipids, such as phosphatidylserine (PS) and phosphatidylethanolamine 
(PE) reside on the inner leaflet (Figure 2-1). PS is unique in that is becomes externalized 
to the outer leaflet of cells undergoing apoptosis, thus, this lipid has become a universal 
marker for apoptosis [52]. Proteins, such as aminophospholipid translocase, are 
responsible for transferring PS and PE to the inner leaflet of the membrane to ultimately 
retain the asymmetric distribution of lipids on the cell [53-55]. During apoptosis, 
however, the protein becomes deactivated by the presence of excess Ca2+ thereby 
disrupting this process and causing a rift in cell homeostasis [55, 56]. Scramblase, an 
ATP-independent protein, becomes activated by the presence of Ca2+ to help actively 
translocate PS and PE lipid molecules across the membrane, suggesting that PS exposure 
is not merely a passive process [57, 58]. Based on several studies, PS exposure during 
apoptosis can be attributed to two factors, the first being the result of impaired 
translocase activity, while the second is a result of scramblase activation [57]. 
To be able to detect and quantify the amount of apoptotic cells in patients would 
be extremely beneficial as a biomedical application in the clinic. For example, high levels 
of apoptosis have been associated with several neurological disorders, including 
Alzheimer’s, Parkinson’s and Huntington’s disease [59]. Conversely, the inhibition of 
apoptosis can lead to excessive cellular proliferation, which is associated with tumor 
growth [60]. The direct recognition and subsequent imaging of PS exposure would not 
only be beneficial for the early detection of disease, but it would also offer a non-invasive 
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approach to monitor the course of treatments that act mainly through induction of 
apoptosis, such as chemotherapy.  
 
2.1.2 Proteins that target phosphatidylserine 
There are several natural receptor proteins that target PS, but perhaps the most 
commonly studied is annexin V, which is a 36 kDa peripheral membrane protein used in 
the clinic to target and bind apoptotic cells. Annexin family proteins generally reside in 
intracellular compartments, but can sometimes be found in the blood, leading to its 
additional properties as anticoagulant agents [61]. It’s main function is to bind 
phospholipids and help recruit macrophages to clear apoptotic cells out of the system 
[62]. The fluorescent and radioactive labeled forms of annexin V have been used to 
image cell death both in vitro [63], as well in animal models and humans [64, 65].  
Although it is the most common method for imaging apoptotic cells, there are several 
drawbacks, including the fact that it requires a Ca2+ cofactor, making it difficult to 
quantify apoptotic cells in the clinic. In addition, this large protein exhibits slow 
clearance rates, high costs of production and is difficult to synthesize and modify [66, 
67]. Alternatively, lactadherin is a 47kDa protein found in milk secreted by mammary 
epithelial cells [68] that can also recognize surface exposed PS to help mediate 
phagocytosis of apoptotic cells [69]. Interestingly, this protein stereoselectively binds PS 
with high affinities, but unlike annexin V, does not require a metal co-factor for binding 
[70]. Lactadherin is emerging as a popular alternative to annexin V, with fluorescently 
labeled derivatives being used to detect PS on cultured cancer cells [71, 72] and on stored 
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platelets [73]. Several studies have been done to investigate the structure of lactadherin, 
including x-ray crystallography and computational analysis [74, 75].  
     
2.1.3 Design of cLac peptide based on computational modeling of lactadherin C2 
domain 
     
Figure 2-2. Computational docking experiments showing diacetyl PS docked to surface 
D of lactadherin and the initial design of cLac based on the structure, PDB: 3BN6. Figure 
adopted from reference [76]. 
The crystal structure of the lactadherin C2 (Lact-C2) domain shows a beta-barrel 
core with three loops that protrude from one end of the structure. Earlier work in our 
group demonstrated that a rationally designed cyclic peptide that mimics the PS-binding 
surface of lactadherin binds apoptotic cells with good selectivity and affinity [76]. The 
initial cyclic lactadherin scaffold, called cLac, was developed using computational 
docking experiments, where a short chain homologue of PC and PS was docked onto two 
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separate surfaces of the C2 domain, Surface C and Surface D, to determine the most 
favorable surface for binding (Figure 2-2). It was determined that loop 3 and surface D 
showed the most favorable binding free energy for the short-chain diacteyl PS. A closer 
look at surface D revealed several key residues displayed in a circular arrangement to 
engage the PS headgroup. The initial cLac design sought to mimic this structural feature 
by linking the same residues through peptide cyclization. More specifically, the 
hydrophobic Phe81 and Trp26 residues act as a membrane insertion motif, while the 
more polar residues, Asp80, His83, Gln95, and Arg148 interact in a selective manner 
with the PS head group.     
  
 
Figure 2-3. Cartoon illustrating the binding event that results in FRET between the Trp 
donor and dansyl acceptor FRET pairs. 
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Figure 2-4. FRET assay demonstrating the dansyl emission increase of cLac-Bip in the 
presence of PS-containing vesicles (left) and a binding curve generated by plotting the 
normalized emission increase against increasing peptide concentrations (right). Figure 
adopted from reference [76] . 
The design of this peptide scaffold began by constructing the hydrophobic 
membrane insertion motif with adjacent Phe and Trp residues, while the computational 
docking model revealed that an Arg projects away from the Lact-C2 domain, making it 
an important residue for docking the PS headgroup. Two glycine-containing regions, 
linker I to connect Gln and Arg, and linker II to connect Arg and Asp were important in 
the rational design of the molecule. Structure activity relationship studies using FRET 
analysis (Figure 2-3) revealed that varying the number of Gly residues on linker II had 
an effect on PS binding, while linker I manipulation showed little change in activity. The 
importance of linker II length is directly related to the critical distance between the Arg 
and Asp residues, which are specifically important for PS headgroup recognition. Lastly, 
the Ile residue projects away from the protein-PS interface, making it an ideal position for 
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functionalization or incorporation of a fluorophore for imaging studies. Additionally, a 
Phe to Biphenyl (Bip) mutation was required for cLac to partition into PS-containing 
vesicles, as the original sequences were relatively inert under those conditions (Figure 2-
4). All of these components, in addition to the structure activity relationship studies, were 
critical in the rational design of the cLac peptide.  
 
2.2 Design of cyclic peptides to test PS recognition 
  
Figure 2-4. Computational docking model of Lact-C2 surface D and diacetyl PS, PDB: 
3BN6. Figure adopted from reference [76].  
In an effort to further understand the contribution each residue on cLac makes in 
targeting PS, we carried out an alanine scan where we selectively mutated specific 
residues to an Ala, then characterized their activities in the presence of PS-containing 
vesicles (Figure 2-5). Before proceeding with this structure activity relationship study, 
however, we sought to establish a robust and efficient synthetic protocol that would allow 
us to access a large library of cyclic peptides. 
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2.2.1 Development of novel intramolecular native chemical ligation reaction 
Previous reports demonstrated the use of a side-chain immobilized Asp residue on resin 
to access the cyclic peptide [76-78]. Using this protocol, the linear sequence can be built 
on the Wang-Asp-OAll resin, followed by an orthogonal alloc deprotection of the main 
chain Asp to expose the free acid, which can then be activated by HBTU and coupled to 
the N-terminal residue to yield the cyclic peptide in decent yields. Due to the harsh 
coupling conditions, however, the reaction yields side products, including peptide dimers, 
as well as chain epimerization. As an alternative, we proposed the use of an 
intramolecular native chemical ligation protocol to accomplish the peptide cyclization 
[79]. In the field of cyclic peptide synthesis, Benkovic and co-workers demonstrated how 
cyclic peptides could be generated in bacterial cells using intein-mediated formation of 
thioesters [80], while Kritzer and co-workers adopted a similar strategy in yeast cells [81]  
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Figure 2-5. Chemical ligation strategies to access cyclic peptides. (a) Standard head-to-
tail cyclization via side chain immobilized Asp residue and N-terminal amino acid using 
orthogonal protecting group to accomplish the cyclization. (b) Intramolecular native 
chemical ligation protocol accomplished using the Dawson Nbz resin via C-terminal 
thioester and N-terminal cysteine residue. Figure adopted from reference [79]. 
The adopted protocol uses the Dawson Dbz resin to build the linear peptide 
sequence on resin, followed by the incorporation of a main chain Boc protected cysteine 
residue to avoid modification at the N-terminus [82]. At the end of the linear peptide 
synthesis, the resin is treated with 4-nitrophenylchloroformate to convert the Dbz group 
into a more labile Nbz moiety for the ligation reaction. Upon global deprotection and 
cleavage from the resin, the peptide is subjected to a ligation buffer that contains an 
excess amount of the exogenous thiol catalyst, either thiophenol or 4-
mercaptophenylacetic acid. During this step, the Nbz moiety is converted to a reactive 
thioester, which rapidly undergoes thiol exchange with the N-terminal cysteine residue, 
followed by an S to N acyl shift to form the amide bond of the cyclic peptide in good 
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yields. One benefit of this reaction is that the thiol can be used as a labeling handle for 
commercially available fluorophores.  
 
Table 2-1. Mass spectrometry data of cyclic peptide library via NCL 
 
Peptide Calculated molecular 
weight 
Molecular weight found 
in mass spectometry 
cLac-wt 1448 Da 1448 Da 
cLac-R/A 1363 Da 1362 Da 
cLac-D/A 1404 Da 1403 Da 
cLac-H/A 1383 Da 1382 Da 
cLac-Q/A 1391 Da 1391 Da 
cLac-H/K 1439 Da 1439 Da 
cLac-Q,H/K 1439 Da 1439 Da 
(L,L)-DiCys 1438 Da 1438 Da 
(L,D)-DiCys 1438 Da 1438 Da 
 
We chose to install a Cys residue for the ligation in linker I region of the original 
cLac peptide sequence, which was shown to better tolerate variations than linker region 
II. Following this modification, we synthesized a library of cLac peptides in which each 
of the PS-binding residues is selectively mutated to an Ala. For the convenience of 
discussion, the Gly to Cys variant is referred to as cLac-wt, while all other peptides are 
called cLac-X/A. 
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2.2.2 Alanine scan of cLac to test PS bnding via FRET  
                
Figure 2-6. a) structure of cLac-wt generated by NCL strategy with polar side chains 
highlighted in red; b) table of cLac mutants for structure activity relationship study; c) 
FRET analysis of cLac-wt and its mutants against vesicles of varying lipid compositions. 
Figure adopted from reference [79]. 
To study the binding interaction between each cLac mutant and a membrane 
containing various compositions of PS, we opted for a FRET-based assay, in which the 
non-fluorophore labeled cyclic peptides were characterized against PC and PS containing 
liposomes. In this assay, the interaction between a peptide and vesicle is characterized by 
the Trp to dansyl emission profile.  Each vesicle contained 5% dansyl-functionalized PE 
lipid to serve as a FRET-acceptor, which in the presence of Trp upon excitation, would 
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yield a high emission profile that could be plotted against increasing peptide 
concentrations to yield a binding curve. 
 The NCL-generated cyclic peptide, cLac-wt, displayed similar PS-binding 
properties to original cLac peptide made through the on resin cyclization strategy, 
indicating that the Cys side chain does not interfere with PS binding. Additionally, the 
increase in dansyl fluorescence is consistent with the percentage of PS found in each 
vesicle composition, meaning that cLac-wt binds 20% PS vesicles four times better than 
it binds 5% PS vesicles.  
 Interestingly, the R/A mutant failed to elicit any fluorescence increase in the 
presence of either PC or PS, indicating that Arg is a critical residue for binding 
phospholipids in general. This is not surprising due to the well-established interaction 
between an Arg headgroup and a phosphate group of the lipid backbone. A binding 
model of lactadherin-PS generated through computational docking experiments suggests 
that an Arg residue forms an interaction with the phosphate group of PS, acting as a 
membrane anchor to help the protein dock into the membrane. Elimination of this 
interaction would explain the dramatic loss in membrane association; further supporting 
claims that Arg is a critical residue in the cLac sequence.  
 In contrast, the D/A mutant displayed significant binding to vesicles containing 
any composition of lipids, either PC or PS, signifying that Asp plays a critical role in 
selectively targeting PS over other lipids. A closer look at the PS headgroup structure 
reveals the presence of a primary amino group, which can form a salt bridge with the 
carboxylic acid of Asp. Removing Asp, however, renders the peptide more cationic, 
making D/A more likely to associate with the anionic PS headgroup. This could explain 
	   41	  
why this peptide exhibits the same affinity to PS as cLac-wt does, but it still binds PC, 
potentially due to the enhancing hydrophobic nature that results from introducing an Ala 
group. The Q/A mutation displays a similar lipid selectivity profile to D/A, but with a 
much less favorable membrane partition, as assessed by fluorescence intensity 
comparison. Based on the binding model, both Asp and Gln are buried within the protein, 
indicating that there is a desolvation penalty associated with binding membranes. Thus, 
their mutation on cLac to the more hydrophobic Ala residue renders the peptides more 
active towards PC-containing membranes because the peptide does not have to desolvate 
the residue while at the same time, has an enhanced hydrophobic driving force, most 
likely causing the loss in selectivity.  
 Perhaps even more interesting is that a His to Ala mutation completely abolished 
the PS selectivity, as demonstrated by both a drop in intensity towards PS-containing 
vesicles, as well as an increase in intensity for PC-only vesicles. Essentially, H/A binds 
all vesicle compositions with nearly equal affinities, which is not surprising since the 
carboxylate group is unique to PS, thus eliminating the His-carboxylate interaction would 
result in a loss in PS selectivity.  
To further validate this result, we synthesized two new cLac mutants, in which we 
introduced either one or two additional cationic residues to the cLac scaffold. In the first 
mutant, H/K, the His residue was mutated to a Lys to ensure that under physiological 
conditions, this side chain displayed a cationic charge that could help to enhance the 
peptide’s ability to associate with anionic membranes. Interestingly, H/K displayed a 
similar binding profile to that of cLac-wt, indicating that it acts through a similar 
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mechanism to bind PS, where the Lys side chain can form a salt bridge with the PS 
carboxylate group.  
 Going a step further, a second Lys mutation was incorporated in lieu of the Gln 
residue, to afford Q, H/K. Due to its higher cationic nature, this mutation was expected to 
further enhance the peptides’ ability to partition exclusively into anionic vesicles. 
However, it was experimentally determined that the peptide binds with nearly equal 
affinity and selectivity as H/K does to PS. The comparable membrane binding observed 
between the two mutants can be attributed to the desolvation penalty associated with 
binding, making the addition of a second cationic residue more entropically costly, 
thereby negating any benefit that the extra charge-charge attraction would introduce. This 
key mutation highlights the necessity to consider desolvation penalties when designing 
peptides that engage in molecular interactions with a given target.  
 
2.2.3 Fluorescent labeling of cLac mutants for fluorescence anisotropy assay 
 
Scheme 2-1. Fluorescent labeling of cLac peptide with fluorescein 5-maleimide. 
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In order to further validate the FRET results, we developed a fluorescence 
anisotropy assay to characterize the interactions between cLac mutants and PC or PS 
containing vesicles. In this assay, the fluorophore-labeled peptide is fixed at a low 
concentration, while increasing amounts of vesicles are titrated into the solution. One 
drawback of the FRET assay is its sensitivity to the local environment, since the emission 
profile is dependent on dipole-dipole coupling interactions between the donor and 
acceptor pairs. Thus, we chose a fluorescence anisotropy assay instead., which 
circumvents this problem since the readout is based only on the excited population of 
fluorophores in a solution, making it a more robust and reliable binding assay than FRET. 
We chose to label cLac-wt and its mutants using the commercially available fluorescein 
5-maleimide, which readily reacts with the free thiol presented on the peptide in an 
aqueous buffer at pH 7.4. 
 
Table 2-2. Fluorescein-labeled cyclic peptide library 
Peptide Calculated 
molecular weight 
Molecular weight found 
in mass spectometry 
cLac-R/A FITC 1790 Da 1790 Da 
cLac-D/A FITC 1831 Da 1831 Da 
cLac-H/A FITC 1809 Da 1809 Da 
cLac-Q/A FITC 1818 Da 1818 Da 
cLac-H/K FITC 1866 Da 1866 Da 
cLac-Q,H/K FITC 1866 Da 1866 Da 
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Figure 2-7. Fluorescence anisotropy results of cLac-wt and mutants using PC and PS-
containing vesicles. Figure adopted from reference [79]. 
The anisotropy results seemed to agree well with the FRET data, further 
supporting our rationalization that all residues on the cLac scaffold work collectively 
towards exclusively binding PS. Specifically, the R/A mutant was completely inert 
towards any vesicles composition, validating the significance of an Arg to target 
membrane lipids. Both D/A and Q/A lost selectivity for PS-containing membranes by 
associating to PC, as well. This phenomenon can also be explained by the fact that an Ala 
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mutation can render the peptide more hydrophobic, which can artificially help the peptide 
bind other targets through hydrophobic interactions. 
Surprisingly, the H/A mutant was not consistent with the FRET results, possibly 
due to a change in the structure upon fluorophore labeling, which may have altered the 
conformation of the cLac peptide in a negative way. Further experiments must be done to 
validate this hypothesis, but overall, the results from the Ala scan are very consistent with 
the FRET-based results. Additionally, the single and double Lys mutation is consistent 
with the FRET results, further validating the negative contribution for binding associated 
with a desolvation penalty. 
Overall, the cLac mutants demonstrate that each residue on cLac-wt contributes to 
PS selectivity and affinity to different degrees. Collectively, all of these functionalities 
are critical in mimicking the parent protein, lactadherin, giving way to many potential 
opportunities to design protein mimics in the future. 
 
 
 
 
 
 
 
 
 
 
	   46	  
2.2.4 Structural analysis of cLac mutants via CD spectroscopy 
 
Figure 2-8. Circular dichroism anaylsis of cLac variants. (a) cLac-wt CD spectra with 
and without Lyso-PS micelles. (b) CD spectra of cLac-wt compared to other mutants. All 
experiments were done at 50 µM peptide concentration and were recorded in a cuvette 
with a 2 mm path length. Figure adopted from reference [79]. 
The cLac peptide structure activity relationship study offered a great deal of 
insight into the contribution of each individual residue of cLac in binding PS. Ideally, 
obtaining structural information of cLac in solution would help us to further understand 
in more detail the specific role each residue and how they are oriented in solution to bind 
the target. However, due to several challenges associated with characterizing a peptide in 
solution, such as solubility and the adaptation of multiple conformers, we opted to study 
the structural features of cLac and its mutants by CD spectroscopy.  
 We measured the CD spectra of cLac-wt in the absence and presence of PS and 
opted for lyso-PS micelles to avoid the light scattering effect associated with using larger 
vesicles. Interestingly, the CD signature of cLac-wt does not significantly change in the 
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presence of PS, indicating that the peptide is quite well preorganized to bind the lipid. 
Specifically cLac-wt displayed a global minimum at 223 nm and two minor features 
around 245 nm and 210 nm, respectively. In contrast, cLac mutants showed a varying 
degree of structure loss in aqueous solution, with all mutants losing the negatively 
ellipticity at 245 nm. Additionally, all mutants displayed a reduction of ellipticity at 223 
nm, with D/A and Q/A completely losing this global minimum. Overall, the data 
presented here indicated that cLac-wt adopts a favorable conformer both in the absence 
and presence of PS-containing vesicles, which helps the peptide partition into these 
membranes without the entropic cost of preorganizing the residues for target binding. 
 
2.2.5. Cross-linked peptide structures to improve binding 
 Our thorough analysis of the cLac peptide has shed some light on the key features 
that are required for binding PS with high selectivity and affinity. Having acquired this 
fundamental knowledge and understanding the chemical contributions of each 
functionality, we sought to further improve upon the structural features of the scaffold.  
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Figure 2-9. Cartoon of the peptide natural product cinnamycin, known to specifically 
recognize a phosphatidylethanolamine (PE) headgroup. Cinnamycin-PE complex was 
generated from the PDB file 2DDE with peptide showing its surface potential (blu: 
positive; red:negative) and lysoPE shown as sticks (C: green; O: red; N: blue; P: orange; 
H: white). Figure adopted from reference [79]. 
It is a well-established fact that structural pre-organization of a receptor can 
reduce the entropic cost for target binding. Countless examples in nature demonstrate 
how folded proteins adopt a well-defined structure for binding a target to carry out a 
specific function. Cinnamycin, for example, is a highly cross-linked peptide natural 
product that exhibits superb selectivity for PE with a Kd value of 10 nM, compared to 10 
mM for PC [83]. The peptide displays four covalent thioether bonds, which help to from 
a binding pocket that is large enough to fit a PE headgroup. An NMR structure of a 
cinnamycin: lyso-PE complex (1:1) revealed that the peptide adopts an overall 
amphipathic structure, with the hydrophobic face containing a single Asp residue within 
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the binding pocket, which is responsible for a polar interaction with the lipid [84]. We 
sought to employ a similar strategy for cLac, where we lock the backbone of the peptide 
in place via bicyclization to help present the key residues for PS binding. 
                          
Figure 2-10. Structure of cLac peptide showing site 1 and site 2, where potential 
functional groups can be incorporated for subsequent stapling reaction to form bicyclic 
peptides. 
Based on computational docking experiments, we chose to introduce the linkage 
between two specific sites on the scaffold where a modification would least perturb the 
peptide. Based on the Lact-C2 crystal structure, the Ile residue projects away from the 
protein-PS binding interface, making it an ideal position to incorporate site 1, while the 
second site would be incorporated in the middle of the glycine linker II region.  The 
stereochemistry of site 1 would be fixed to L, while site two would be either L or D, since 
there is no further structural information to support its optimal orientation in solution.  
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2.2.6 Strategies for stapling peptides 
               
 
Scheme 2-2. Synthetic route to access azido lysine and derivatives from commercially 
available amino acids. Conversion of an amino group to an azido group can be 
accomplished through a diazotransfer reaction. 
We initially opted for an azide-alkyne click reaction to generate the peptide staple 
by incorporating an L-propargyl glycine at site 1 and either an L, or D-azido lysine 
derivative at site 2. Since both sites are spaced apart so that each is on an opposite end of 
the scaffold, we could control the length of the linker by incorporating azido lysine 
derivatives with shorter backbones. We synthesized a library of L and D-azido-lysine 
derivatives by subjecting Fmoc protected Dap, Dab, Orn or Lys to the diazotransfer 
reaction to convert the amino group to an azide.   
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Scheme 2-3. Structure of monocyclic cLac peptide with a propargyl and an azido group 
incorporated at site 1 and 2, respectively to yield the bicyclic peptide product through 
click chemistry. 
During the cyclization conditions, however, the azido group became reduced by 
TCEP, rendering it inert to the subsequent click reaction. Due to this synthetic challenge, 
we turned to an alternative strategy, in which we abandoned an intramolecular stapling 
reaction and turned to an intermolecular route to access the bicyclic peptides.  
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Scheme 2-4. 2-iodoacetyl chloride reaction with aliphatic diamines (left) or heterotom-
incorporated diamines (left) to yield iodoacetamide linker for peptide bicyclization. 
In this strategy, we introduce two cysteine residues at site 1 and 2 of cLac, 
followed by a reaction with an iodoacetamide linker to yield the bicyclic peptide. The 
benefit of using this strategy is that only two cyclic peptides are synthesized, one with (L-
Cys, L-Cys) stereochemistry and the other with (L-Cys, D-Cys) stereochemistry. We can 
then react each monocyclic peptide with iodoacetamide linkers of various lengths, to 
yield the bicyclic peptides, which can then be purified and analyzed by FRET to 
determine their efficacies towards PS-containing membranes.  
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Scheme 2-5. cLac bicyclization reaction through iodoacetamide linkage between two Cys 
residue in the monocyclic peptide sequence. 
A library of iodoacetamide linkers was designed with some containing a 
hydrophobic chain, while others contained a heteroatom within the chain. They were all 
synthesized from the commercially available diamine precursors, which were then 
incubated with 2-iodoacetyl chloride and potassium carbonate in a mixture of water and 
chloroform, overnight. A DMF stock of each linker was prepared for the subsequent 
bicyclization reaction with the peptides, which was accomplished by incubating each 
peptide in a mixture of DMF and PBS with TCEP, then adding two equivalents of the 
linker and heating for 1 hour or until the reaction was complete by LC-MS. 
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Table 2-3. Bicyclic peptide library accessed through iodoacetamide chemistry 
Peptide Calculated 
molecular weight 
Molecular weight found 
in mass spectometry 
(L,L)-DiCys ethyl 1578 Da 1579 Da 
(L,L)-DiCys propyl 1592 Da 1593 Da 
(L,L)-DiCys butyl 1606 Da 1606 Da 
(L,L)-DiCys pentyl 1620 Da 1621 Da 
(L,D)-DiCys ethyl 1578 Da 1579 Da 
(L,D)-DiCys propyl 1592 Da 1593 Da 
(L,D)-DiCys butyl 1606 Da 1607 Da 
(L,D)-DiCys pentyl 1620 Da 1621 Da 
 
2.2.7 Results of iodoacetamide crosslinked cLac peptides 
 
Figure 2-11. Representative FRET plot of bicyclic peptide activity towards PC and PS-
containing vesicles. 
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A library of 8 bicyclic peptides was generated using this method, followed by 
their analysis by FRET. Surprisingly, none of the peptides showed promising results and 
were essentially inactive towards vesicles of any PC or PS composition, indicating that 
the staple was introducing unfavorable structural changes to the cLac scaffold.  
 
Figure 2-12. Comparison of bicyclic peptides to the monocyclic (L,D)-DiCys perecursor, 
as well as the positive control, peptide cLac-Q,H/K. 
 To investigate this hypothesis even further, we analyzed the dicysteine-containing 
monocyclic peptides alone and discovered that they are also inactive against PC and PS 
containing vesicles, signifying that incorporation of two cysteine residues at those 
positions leads to unfavorable activity towards vesicles. Additionally, the positive 
control, Q, H/K, displayed PS-binding, indicating that there was no issue with the quality 
of the vesicles and the negative binding of the bicyclic sequences can be interpreted as 
real.  
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2.3 Conclusion 
Overall, efforts towards investigating the key properties of the rationally designed 
cLac peptide have been fruitful. We have come to understand, through an Ala scan, the 
contribution of each amino acid on the scaffold towards PS recognition and will 
hopefully utilize this knowledge in the future to design more efficient sequences. 
Additionally, we have optimized an intramolecular native chemical ligation protocol, 
which enables us to synthesize libraries of cyclic peptides with various modifications to 
the sequence. CD spectroscopy analysis was informative, as we learned that mutations at 
any position on cLac led to some degree of structure loss, which could have contributed 
to either the loss of affinity or selectivity. Furthermore, the SAR study may have 
foreshadowed our results with the bicyclic peptide sequences, as the introduction of an 
extra cysteine residue on the scaffold seemed to negate the binding altogether. 
Collectively, all of these results demonstrate the importance in trying to understand the 
components that make up a good receptor and what role each functional group plays in 
binding a desired target. 
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Experimental Procedures 
I. General methods 
Dawson (3-(Fmoc-amino)-4-aminobenzoyl) resin and HBTU were purchased from 
Novabiochem (San Diego, CA). 4-nitrophenyl chloroformate, fluorescein-5-maleimide, 
Tris base, and guanidine hydrochloride were purchased from Thermo Fisher Scientific 
(Wal- tham, MA). 4-Mercaptophenylacetic acid was purchased from Sigma Aldrich (St. 
Louis, MO). The phospholipids were purchased from Avanti Polar Lipids (Alabaster, 
AL). Fmoc-(4,4’)-Biphenylalanine (Fmoc-Bip) was purchased from Chem-Impex Int’l 
Inc (Wood Dale, IL). All other Fmoc-protected and Boc-protected amino acids were 
purchased from Advanced Chemtech (Louisville, KY) or Chem-Impex Int’l Inc (Wood 
Dale, IL). Peptide synthesis was carried out on a Tribute peptide synthesizer (Protein 
Technologies, Tuscon, AZ). Peptide concentration measurements were performed on a 
Nanodrop 2000c Spectrophotometer (Thermo Fisher Scientific, Waltham, MA).  
II. Peptide synthesis and characterization 
The cLac peptides were synthesized through Fmoc/t-Bu chemistry using preloaded 
Dawson Dbz resin (3-(Fmoc-amino)-4- aminobenzoyl AM resin, Novabiochem), which 
consists of a 3,4- diaminobenzoic acid attached via the carboxyl group to the resin. The 
syntheses were carried out on a 0.05 mmol scale using 5 equiv of the Fmoc-protected 
amino acids and HBTU for the coupling reaction. Additionally, a main-chain Boc-
protected cysteine residue was in- stalled at the terminal position of the peptide. A 
mixture of 50 mg 4- nitrophenylchloroformate in 1 mL of dichloromethane was added at 
the end of the synthesis and allowed to shake for 2 h to afford the C- terminal 
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imidazolidinone Nbz moiety, which will later facilitate the thioester formation in the 
subsequent native chemical ligation (NCL) reaction. The peptides were cleaved off the 
resin and globally deprotected using Reagent K (80% TFA, 5% H2O, 2.5% EDT, 5% 
thioanisole, and 7.5% phenol). The crude products were purified by RP- HPLC (Waters 
Prep LC, Juniper C18 Column). All peptides were characterized with LC-MS to confirm 
their identities and purities.  
III. Native Chemical ligation 
The NCL reaction was carried by modifying a reported procedure [85]. The linear 
peptide was dissolved in a mixture of DMF and ligation buffer (0.2 M sodium phosphate, 
3 M guanidinium chloride, 20 mM 4-mercaptophenylacetic acid, pH 8) to a concentration 
of 2 – 5 mM. An equal amount of TCEP was added with respect to peptide concentration. 
The reaction mixture was allowed to sit at room temperature with complete conversion in 
4 h. The reaction mixture was acidified with buffer A (95% H2O, 5% ACN, 0.1% TFA) 
and purified by RP- HPLC (Waters Prep LC, Juniper C18 column) to afford the cyclic 
peptide in 60-70% yield. All peptides were characterized with LC-MS analysis to 
confirm their identities and purities. The peptide concentrations were calibrated by 
measuring the UV absorption at 275 nm (εBip, 275 = 11200 M-1cm-1, εTrp, 275 = 5379 11200 
M-1cm-1, εpeptide, 275 = 11200 M-1cm-1) [86, 87] . 
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III. Fluorophore labeling 
The labeling reaction was carried out by preparing a cyclic peptide stock in DMF, 
then adding 1 equivalent of fluorescein maleimide and 2% v.v. N-methylmorpholine in 
DMF until the peptide concentration reached 200 µM. Additionally, 1 equivalent of 
TCEP with respect to the peptide was added to ensure that the thiol was reduced and 
readily available for labeling. The reaction mixture was left to sit at room temperature in 
the dark and complete conversion was achieved in 1 h. The reaction mixture was purified 
by RP-HPLC (Waters Prep LC, Juniper C18 column) to afford the labeled product. All 
peptides were characterized with LC-MS analysis to confirm their identities and purities. 
The peptide concentrations were calibrated by measuring UV absorption at 495 nm 
(εfluorescein,495= 80,000 M
-1cm
-1, εpeptide,495= 80,000 M
-1cm
-1).  
(d) Iodoacetamide linker synthesis     
Iodoacetamide linkers were synthesized according to the following protocol. Diamino 
(ethane, propane, butane and pentane) (1 equivalent) was dissolved in a 1:1 mixture of 
H2O:CHCl3 and left to stir for 5 minutes at 0 °C.  K2CO3 (1 equivalent) was slowly added 
to the solution, followed by the addition of 2-iodoacetyl chloride (2 equivalents) and the 
reaction was left to stir overnight. The organic layer was separated and washed with H2O 
(3x), dried over Na2SO4 and concentrated in vacuo. The crude material was purified by 
silica gel chromatography (1:3 EtOAc: hexanes) to yield the desired product in 40-60% 
yield. 
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(a) N,N’-(ethane-1,2-diyl)bis(2-iodoacetamide) 1H NMR: CD3OD, 500 MHz, δ=3.447 
(s, 4H), 3.708 (s, 4H). HRMS calculated for C6H10I2N2O2+ [MH+] 396.8909, found 
396.8914. 
(b) N,N’-(propane-1,3-diyl)bis(2-iodoacetamide): 1H NMR: CD3OD, 500 MHz, 
δ=1.719-1.678 (m, 2H), 3.307-3.198 (m, 4H), 3.681 (s, 4H). HRMS calculated for 
C6H10I2N2O2+ [MH+] 410.9066, found 410.9070. 
© N,N’-(butane-1,3-diyl)bis(2-iodoacetamide) 1H NMR: CD3OD, 500 MHz, δ=1.557-
1.530 (m, 4H), 3.197-3.171 (m, 4H), 3.666 (s, 4H). HRMS calculated for C8H14I2N2O2+ 
[MH+] 424.9222, found 424.9224. 
(d) N,N’-(pentane-1,3-diyl)bis(2-iodoacetamide) 1H NMR: CD3OD, 500 MHz, 
δ=1.401-1.363 (m, 2H), 1.558-1.499 (m, 4H), 3.182-3.154 (m, 4H), 3.667 (s, 4H). HRMS 
calculated for C9H16I2N2O2+ [MH+] 438.9368, found 438.9363. 
VI. Peptide bicyclization 
The iodoacetamide bicyclization reaction proceeded by preparing a 200 µM stock of 
cyclic peptide (L,L) DiCys or (L,D) DiCys in a 1:1 mixture of DMF and NaPi buffer, pH 
7.4. 5 equivalents of TCEP was added and the solution was heated at 60 °C for 30 
minutes, followed by the addition of the linker in a concentrated DMF stock (ethyl, 
propyl, butyl, pentyl). The reaction was monitored by LC-MS and upon completion, was 
dilution in buffer A and directly purified by RP-HPLC (Waters Prep LC, Juniper C18 
column) to afford the bicyclic peptides in 40-60% yields. All peptides were characterized 
with LC-MS analysis to confirm their identities and purities. The peptide concentrations 
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were calibrated by measuring the UB absorption at 275 nm (εBip, 275 = 11200 M-1cm-1, 
εTrp, 275 = 5379 11200 M-1cm-1, εpeptide, 275 = 11200 M-1cm-1).  
VII. Liposome preparation 
Dansyl-labeled 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) was 
synthesized according to the reported protocol [88]. Liposomes were prepared by 
dissolving and mixing the desired phospholipids in chloroform. The solvent was removed 
using high vacuum for 6 h and the residue was suspended in 50 mM Tris buffer, pH 7.4. 
The lipid suspensions were treated through 20 cycles of a ‘freeze-and-thaw’ process and 
extruded 21 times through a membrane with a diameter of 100 nm. The concentrations of 
liposome stocks were characterized via the Stewart assay [89]. Liposomes for the 
fluorescence anisotropy assay were prepared in the same manner as stated above, with the 
exception of in-corporating the dansyl-labeled POPE.  
VIII. FRET binding assay 
The liposome binding of the cLac peptides were evaluated by monitoring the dansyl 
emission upon addition of peptides. The experiments were carried out on a SpectraMax 
M5 plate reader (Molecular Devices, Inc. Sunnyvale, CA) with a quartz cuvette of 10 mm 
path length. The samples were excited at 280 nm and their emission was monitored from 
320 nm to 530 nm. All peptides were dissolved in DMF to give a 1 mM stock. The tests 
were done at a total lipid concentration of 100 µM and peptide concentration of 10 µM. 
The dansyl emission intensity at 520 nm was plotted against increasing peptide 
concentrations.  
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IX. Fluorescence anisotropy assay 
The fluorescence anisotropy experiments were carried out on a Cary Eclipse 
Spectrophotometer (Agilent Technologies) with a quartz cuvette of 10 mm path length. 
Prior to measurements, a G factor of 1.4213 was calculated for the fluorophore on the 
instrument. All fluorescein-labeled peptides were dissolved in DMF to give a 100 mM 
stock. The experiments were performed at a peptide concentration of 100 nM prior to 
liposome titration. The samples were excited at 495 nm and their emission was monitored 
at 520 nm to afford the anisotropy values. An increasing amount of liposome was titrated 
into the cuvette and the anisotropy values were measured at each concentration of 
liposome. The anisotropy values were plotted against liposome concentration to give the 
binding curves.  
X. Circular dichroism measurements 
The CD experiments were performed on an Aviv Model 420 CD Spectrometer (Aviv 
Biomedical, Inc., Lakewood, NJ). All samples for the wavelength scans were prepared in 
buffer (PBS, pH 7.4) at a concentration of 50 µM and placed in a quartz cuvette with a 2 
mm path length. The CD spectra were recorded from 190 to 260 nm at 2 °C with a 10 s 
averaging time for each measurement. The lysoPS experiment was performed by titrating 
2 mM of the micelles from a concentrated stock of 55 mM into the peptide sample.  
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Chapter 3. A prolinomycin-based scaffold for developing functional peptides 
 
3.1 Introduction 
Nature has evolved proteins to bind cell-signaling molecules with exquisite 
affinity and specificity, making molecular recognition an essential part of biology. It has 
been a highly sought after goal within the chemistry field to be able to mimic the 
structure and function of certain proteins with smaller molecules, such as peptides [90]. 
Compared to proteins, which are large in size, peptides are easier to chemically modify, 
label and functionalize. More specifically, cyclic peptides exhibit high proteolytic 
stabilities and faster clearance rates compared to proteins, making them more attractive 
candidates for some clinical applications [91]. Although peptides are showing promise as 
therapeutic agents, it is challenging to rationally develop peptides that exhibit desirable 
functions.  
 
3.1.1 Peptide receptor preorganization 
One of the advantages that peptides have over small molecules is that they can 
engage a target through multiple interactions, much like a protein would. However, 
unlike a protein, peptides generally do not possess the ability to properly fold and display 
their side chains for target binding. In fact, it is energetically costly for a peptide to 
structure itself in solution and bind its intended partner. One way to circumvent this 
problem is to preorganize the side chains on a peptide scaffold, thereby locking the 
residues in place for a more favorable target interaction. This can be done by chemically 
modifying the structure to incorporate a staple, which would lock the conformation in 
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place, as seen in several examples with α-helices and cyclic peptides [92, 93]. However, 
without solid structural information, it is challenging to predict whether a staple would 
favor, or destabilize the structure when incorporated into the scaffold.  
Herein, I will describe a novel strategy that takes advantage of the structural 
features of prolinomycin, a rigid peptide macrocycle, to develop protein-like receptors 
with high target specificity and affinity. Prolinomycin is unique in that it can undergo 
metal-nucleated folding in water to afford a highly structured peptide scaffold, which can 
be amenable to side chain mutations. I will demonstrate that in the presence of a K+ ion, 
this peptide and its mutants can display protein-like folding in both vesicle and cell-based 
assays.  
 
3.1.2 Metal-complexation of the natural product valinomycin and its structural 
analogue, prolinomycin 
 
            
Figure 3-1. Structure of valinomycin with ester linkages (left) and prolinomycin with 
amide linkages (right) 
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Valinomycin is a depsipeptide antibiotic that has been widely investigated due to 
its ability to complex and transport monovalent cations (Figure 3-1) [94]. The carbonyl 
oxygens of valinomycin point inwards to form a polar cavity, to chelate K+, thereby 
causing the hydrophobic side chains to point outwards [95, 96]. This critical change in 
structure facilitates the peptide to shield a K+ ion from the bulk solvent and transport it 
across lipid bilayers. Acting as an ion shuttle, the peptide crosses the membrane to 
dissociate the K+ ion, which disrupts the electrochemical gradient of the cell, leading to 
cell death. 
In addition to spectroscopic methods, the metal-complexed structure of 
valinomycin has been characterized by x-ray crystallography to suggest that replacing its 
ester linkages with amide linkages should not perturb the overall geometry. Using this 
information, Gisin and Merrifield developed prolinomycin, a structural analogue of 
valinomycin, by replacing the ester linkages with proline residues possessing the same 
chirality [97]. Subsequent studies led them to discover that prolinomycin has a higher 
affinity for monovalent cations than its predecessor, valinomycin, but is a poor 
transporter through the lipid bilayer [98]. This can be attributed to the restricted freedom 
of rotation from the proline residues, which forces the uncomplexed peptide into an 
unfavorable, high-energy structure. In the presence of K+ or Rb+, the highly strained 
peptide has more incentive to bind the cation and adopt a lower energy conformer [99]. 
Conformational analysis of prolinomycin in the presence of cations was performed using 
spectroscopic methods to confirm peptide-metal chelation [100]. Additionally, proline 
residues prevent the peptide from dissociating the metal efficiently, making it a poor 
antibiotic candidate due to its inability to act as an ion shuttle. Although the properties of 
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prolinomycin differ from valinomycin, its unique structural features offer considerable 
potential for alternative applications. 
 
3.2 Design of prolinomycin analogues 
    
Figure 3-2. Prolinnomycin structure top view (left) and side view (right).  
We sought to take advantage of the structural features of prolinomycin and design 
a protein-like receptor for target binding. As seen in the crystal structure of wild type 
prolinomycin, the metal-induced folding ability allows the peptide to adopt a “drum-like” 
structure with each deck displaying their side chains in opposite directions (Figure 3-2). 
A key feature of this scaffold is the presence of multiple proline residues, which are 
critical for the slow K+ dissociation in water. We hypothesized that the non-proline side 
chains on the top deck of the peptide could be mutated to residues that engage in 
favorable interactions with a given target. In order to test whether the scaffold could 
tolerate any mutations to the non-proline residues, we incorporated non-beta branched 
amino acids in lieu of the Val residues.  
One of the overarching goals of this lab has been to develop receptors with high 
affinities and specificities for membrane lipids. As mentioned earlier, lipids play a 
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 We anticipate the expanded structures of prolinomycin to accommodate larger guest molecules 
that are biologically important. For example, cardiolipin (CL) and lysyl phosphatidylglycerol (Lys-PG) 
are two exemplary lipids with larger headgroups (Figure 8). Both of them are abundant in bacterial 
cells, while absent from mammalian cell surfaces.20,21 Synthetic molecules that target CL or Lys-PG 
would be useful for imaging applications of bacterial infection. Furthermore, while CL is absent from the 
plasma membrane of mammalian cells, it is highly enriched in mitochondria. Changes of CL 
concentration has been suggested to cause significant alterations of mitochondria function. Synthetic 
molecules targeting CL may allow further elucidation of the roles that CL plays in mitochondrial biology 
as well. We submit that the ring-expanded prolinomycins may serve as suitable scaffolds to achieve 
selective recognition of these larger membrane lipids.  
We will synthesize the ring-expanded prolinomycin analogues by using the mPro-mediated 
cyclization (Figure 4). It is likely that the Prol4 and Prol5 sequences as shown in Figure 7 are not well 
soluble in water. To avoid the solubility problem, we will make their mutants incorporating polar 
residues similar to the NRD mutant of prolinomycin. The peptide variants will be characterized with 
NMR spectroscopy to probe their structural preference. We anticipate these Prol4 and Prol5 variants to 
be conformationally rigid, therefore amendable to computational design as prolinomycin is. Once the 
conformational rigidity is confirmed, we will use Prol4 and Prol5 as scaffold to develop synthetic 
receptors for larger membrane lipids including CL and Lys-PG. This branch of research will be included 
as a major aim in our R01 renewal (see Leveraging Plan for 
details).   
 
Figure 7. Predicted structures of prolinomycin and ring-expanded analogues. The 
peptide sequences are shown at the bottom with D-amino acids underlined.  
Conclusion. This IGNITE application seeks support to establish an exciting new direction of our 
research program. The proposed work, combining the strength of computational chemistry (Haeffner) 
and experimental chemical biology (Gao), will result in a unique and powerful approach to the 
development of peptide macrocycles that target specific lipids.  Such lipid-binding molecules will find 
applications in multiple areas of biomedicine. We believe the synergy between computation and 
experiment, as wel  a  the novelty of t e prolinomycin scaffolds, will make this a highly competitive 
program for exter al funding.  
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significant role as signaling molecules in biology, often recruiting proteins to the 
membrane surface to perform critical functions. In mammalian cells, the anionic lipid PS 
is confined to the cytosolic leaflet and only becomes surface exposed during apoptosis. 
Conversely, bacterial cell membranes are abundant in anionic lipids, making cationic 
antibiotics a main route to target and kill these cells. To begin, we decided to employ a 
general approach and develop a cationic analogue of prolinomycin that could target the 
anionic lipids of a bacterial cell membrane. Due to the well-established interaction 
between arginine and phosphate groups on membrane lipids, we chose to design a poly-
arginine sequence.  
 
3.2.1 Synthesis of prolinomycin analogues via proline ligation 
We sought after an efficient cyclization method that would yield high conversion 
and product purity. The native chemical ligation (NCL) strategy is a chemoselective 
method to synthesize cyclic peptides with high yields and purities [79]. Cyclization can 
be accomplished in solution without side chain protecting groups, making it an optimal 
approach to expand a library of mutants. Additionally, a free thiol displayed on the 
peptide after the cyclization can be used as a labeling handle for subsequent fluorescence-
based experiments.  
	   68	  
          
Scheme 3-1. Solid phase synthesis of the RRR linear precursor peptide. 
Due to the high frequency of proline residues within the sequence, we adopted an 
intramolecular proline ligation protocol, which enables the chemoselective reaction 
between an N-terminal thioproline (tPro) and a C-terminal thioester on the peptide 
sequence [101, 102]. In order to secure high cyclization yields, we also chose to install an 
Ala residue in lieu of Val at the C-terminus, since the branched structure of Val could 
impede the reaction. Using this modified intramolecular proline ligation strategy, we built 
the linear peptide sequence on a Dawson Dbz resin using solid phase peptide synthesis 
(SPPS), followed by incorporation of (2S, 4R)-Boc-Mpt(Trt)-OH (tPro) at the N-terminus 
(Scheme 3-1). The Dbz moiety was then converted to the more reactive Nbz group by 
formylation with 4-nitrophenylchloroformate. Although the sequence contains a high 
frequency of proline residues, which are traditionally thought to be difficult couplings, 
LC-MS analysis revealed a relatively pure linear peptide. After global deprotection and 
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cleavage from the resin, the crude linear peptide was subjected to the ligation reaction 
conditions to yield a relatively clean conversion to the cyclic product. 
 
 
Scheme 3-2. Synthesis of RRR via intramolecular proline ligation. 
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Figure 3-3. Synthesis of prolinomycin mutants. a) Exemplary HPLC traces of 
prolinomycin synthesis via proline ligation. Top: LC trace of the crude RRR linear 
precursor (1*). Bottom: LC trace of the ligation reaction at 16 h showing full conversion 
of linear precursor (1*) to cyclic peptide (2*). Other side products and compounds 
include TCEP (2a), Nbz (2b), hydrolyzed linear peptide (2c) and 4-mercaptophenylacetic 
acid (2d). b) ESI-MS spectra of the RRR linear precursor (top) and the ligation mixture at 
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16 h showing conversion of the linear peptide to the desired cyclic product. c) LC-MS of 
the purified RRR cyclic peptide. LC-MS analysis was carried 220 nm.  
During the ligation reaction, a thiol exchange occurs between the N-terminal tPro 
and C-terminal thioester, forming a 5-membered ring transition state, which then 
undergoes an S to N acyl shift (Scheme 3-2). Therefore, it is crucial to use the trans 
diastereomer of tPro to allow this step to proceed easily, since the cis-diastereomer would 
sterically hinder the reaction to yield little or no conversion to the cyclic product (Figure 
3-3). Additionally, few side products were formed during the ligation reaction, suggesting 
that the route can be a powerful tool to synthesize large libraries of prolinomycin mutants 
for screening and analysis further down the line. 
In addition to RRR, we synthesized and characterized a diverse library of mutants 
to further investigate our hypothesis. These cyclic peptides were synthesized via the 
proline ligation strategy and will be discussed later on in this chapter. The sequences and 
masses can be found in Table 3-1. 
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Table 3-1. Sequences and masses of cyclic peptides 
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3.2.2 NMR analysis of RRR peptide 
                         
Figure 3-4. 1H NMR (600 MHz) spectra of the RRR amide region with varied 
concentrations of K+. The peak at 6.14 ppm corresponds to maleic acid used as an 
internal standard (0.2 mM). Sample is in 10% D2O in 1:1 CD3OH:NaPi buffer, pH 4.0. 
We sought to investigate the metal-nucleated folding ability of prolinomycin 
mutants by 1H NMR spectroscopy to ensure that a mutation of Val to any other amino 
acid would not disrupt the peptide’s ability to bind potassium. Due to potential solubility 
and aggregation issues, we chose to analyze the peptide at 0.2 mM concentration in a 
buffer containing 10% D2O and a 1:1 mixture of CD3OH and NaPi at pH 4.0. We used 
methanol d-3, as well as pH 4.0, to minimize the potential deuterium exchange with the 
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amide protons. Interestingly, in the absence of K+ ions, no clear peaks were observed in 
the amide proton region of the spectrum of the RRR peptide, indicating that several 
conformers could simultaneously exist in solution and would likely be exchanging. 
However, addition of KCl to the solution elicited the appearance of well-resolved peaks, 
which can be attributed to intramolecular hydrogen bonding of the amide protons to 
adjacent carbonyl oxygens; induced by metal-complexation of the remaining carbonyl 
oxygens (Figure 3-4).  
          
Figure 3-5. Metal-nucleated folding of prolinomycin mutants. Titration curve generated 
by plotting the peak integration at 7.95 ppm against KCl concentration.  
 The integrated area of the peak at 7.95 ppm was plotted against KCl concentration 
to yield a binding curve with a Kd value of approximately 2 mM for K+ binding (Figure 
3-5). Although this value is in agreement with physiologically relevant concentrations of 
potassium, it is still higher than wild type prolinomycin, which has a reported value of 10 
µM. The underlying reasons for the difference remain to be defined. 
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Figure 3-6. Metal-nucleated folding of prolinomycin mutants. A dilution experiment 
highlighting the dynamic nature of RRR for K+ binding. 
Additionally, a dilution experiment of RRR demonstrates that the K+ chelation is 
reversible as select NH resonances rapidly disappear with a drop in KCl concentration 
(Figure 3-6). This result not only demonstrates the dynamic nature of K+-binding, but 
more importantly, illustrates that the peptide can adopt a well-folded structure under 
physiological conditions. 
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Figure 3-7. 1H NMR spectra of the RRR aliphatic region with varied concentrations of 
K+. Sample is in 10%D2O in 1:1 CD3OH:NaPi buffer, pH 4.0. 
Focusing on the aliphatic region of the 1H NMR spectrum of the RRR KCl 
titration experiment, we observe that K+ ions can also induce favorable structural changes 
of the peptide side chains (Figure 3-7). Specifically, we observe the emergence of a 
doublet at 0.88 ppm, which we attribute to a Val side chain, as well as the emergence of a 
doublet at 1.32 ppm, which is an Ala side chain. The increasing sharpness of these peaks 
with the addition of K+ suggests a reduction in the number of peptide conformers in 
solution. Although these experiments provide a great deal of information on how the 
peptide behaves in the presence of K+, the experimental conditions do not fully represent 
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how the peptide would behave in a pure aqueous environment, since the solvent contains 
50% CD3OH.  
              
Figure 3-8. 1H NMR spectra of the RRR amide and aliphatic regions showing a CD3OH 
titration profile. The peptide concentration is initially at 1 mM in 10%D2O: NaPi buffer, 
pH 4.0 with 100 mM KCl. Prior to adding CD3OH, an equal volume of the sample was 
removed.  
To address this issue, we performed a CD3OH titration experiment to further 
examine how methanol can affect the peptide’s behavior in solution. We prepared a 1 
mM sample of RRR in 10%D2O: NaPi buffer, pH 4.0 and added a fixed concentration of 
KCl (100mM) to ensure that the peptide is fully bound to K+. As seen in Figure 3-8, at 
0% CD3OH, the peaks in both the amide and aliphatic regions of the spectrum are broad 
and not well resolved, indicating that the peptide may aggregate, or adopt several 
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conformers under these conditions. An identical sample of the peptide in CD3OH with 
KCl was prepared and titrated into the sample at 10% by volume increments. Prior to the 
titration, an equal volume of the aqueous solution was removed in order to minimize any 
dilution. Interestingly, the addition of CD3OH seems to help the NMR resonances 
become much more resolved, which could be the result of multiple factors. The high 
concentrations required to perform the NMR experiments may cause the peptide to 
aggregate in a purely aqueous environment, which could explain why we observe broad 
peaks, even in the presence of K+. The addition of CD3OH helps to break up these 
peptide aggregates, which in turn causes the peaks to become sharper.  
       
Figure 3-9. 1H NMR data of amide and aliphatic regions demonstrating K+ selectivity of 
RRR. Peptide sample is at 1 mM concentration in 10%D2O/NaPi buffer, pH 4.0. Top 
trace shows peptide without added salt. Middle trace shows peptide with the addition of 
100 mM NaCl. Bottom trace shows peptide with an additional 100 mM KCl. 
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 Although the RRR peptide does not exhibit ideal behavior in a purely aqueous 
environment, we can still make some key observations about its structure. The KCl 
titration data clearly showed that RRR responds well to an influx of K+ ions, by chelating 
the metal to form a reduced number of conformers in solution, as observed by the 
emergence of amide proton resonances. We were interested in further studying the ion 
selectivity of RRR in a purely aqueous environment, so we prepared a 1 mM sample of 
the peptide in a 10%D2O/NaPi buffer at pH 4.0 with no additional salt (Figure 3-9). We 
then added 100 mM of NaCl to the sample and did not observe any change in the NMR 
spectrum, indicating that Na+ ions do not induce any change to the peptides 
conformation. Interestingly, if we add an equal amount of KCl (100 mM) to the same 
sample, which already contains NaCl, we observe a clear change in both the amide and 
aliphatic regions of the spectrum. More specifically, the amide protons become 
prominent and side chain resonances in the aliphatic regions become slightly sharper, 
which is consistent with earlier data seen in. 
Collectively, the NMR results for RRR demonstrate the dynamic nature of the 
cyclic peptide in both a purely aqueous environment, as well as a mixture of methanol 
and water. We observe the K+-induced conformational changes of RRR by the emergence 
of amide proton resonances, as well as the sharpening of peaks in the aliphatic region of 
the spectrum. Additionally, the metal-induced folding of RRR is selective for potassium, 
as sodium ions do not induce any significant changes to the NMR spectrum. To 
investigate the generality of this phenomenon, we analyzed two additional prolinomycin 
mutants by NMR.  
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3.2.3 NMR analysis of RRR-4W peptide 
              
Figure 3-10. 1H NMR spectra of the RRR-4W amide region with varied concentrations 
of K+. The peak at 6.14 ppm corresponds to maleic acid used as an internal standard (0.2 
mM). Sample is in 10%D2O in 1:1 CD3OH:NaPi buffer, pH 4.0. 
 The RRR-4W mutant is almost identical to RRR in sequence, except that it 
contains a Trp residue in lieu of a Val. Not surprisingly, the peptide also behaves similar 
to RRR in the KCl titration experiment (Figure 3-10). Increasing the concentration of K+ 
ions in solution helps to elicit the emergence of amide proton resonances.  
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Figure 3-11. 1H NMR spectra of the RRR-4W aliphatic region with varied 
concentrations of K+. Sample is in 10%D2O in 1:1 CD3OH:NaPi buffer, pH 4.0. 
 Additionally, the aliphatic region of the NMR spectrum shows a doublet from Ala 
at 1.25 ppm, which becomes more resolved with increasing KCl concentration. Two 
doublets at 0.85 ppm and 0.92 ppm also emerge, which we assign to the methyl groups of 
Val. Together, the data suggest that RRR and RRR-4W behave in a relatively similar 
manner under the same conditions (Figure 3-11).   
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Figure 3-12. 1H NMR spectra of the RRR-4W amide region with varied concentrations 
of K+. The peak at 6.14 ppm corresponds to maleic acid used as an internal standard (0.2 
mM). Sample is in 10%D2O/NaPi buffer, pH 4.0. 
 We were interested in further investigating the K+-induced folding of RRR-4W in 
a pure aqueous solution. A peptide sample was prepared at a 0.2 mM concentration in 
10%D2O in NaPi buffer at pH 4.0 and increasing concentrations of KCl were added to the 
solution. As seen in figure 3-12, the amide protons only emerge at high concentrations of 
KCl, which is likely the result of the more difficult desolvation of ions in 100% water 
versus a mixture of water and methanol.                    
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Figure 3-13. 1H NMR spectra of the RRR-4W aliphatic region with varied 
concentrations of K+. Sample is in 10%D2O/NaPi buffer, pH 4.0. 
Concomitantly, with the change observed in the amide proton region, the peaks 
corresponding to the Ala and Val methyl groups do not display well-resolved doublets 
until high concentrations of potassium. These characteristic signatures in the spectrum 
potentially indicate the convergence of several conformers to a single structure in 
solution (Figure 3-13). 
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Figure 3-14. Kinetic study of RRR-4W peptide with 20 mM KCl over several hours. 
 RRR-4W responds to high concentrations of K+ ions in a purely aqueous 
environment, whereas in a mixture of methanol and water, the Kd value is much lower. 
This is not surprising, due to the intrinsic difficulty in desolvating an ion in water, versus 
a mixture of water and organic solvent. However, to ensure that the lack of chelation at 
lower potassium concentrations was not due to slow kinetics, a sample of RRR-4W was 
prepared under the same conditions (0.2mM peptide, 10% D2O in NaPi buffer, pH 4.0) 
but only 20 mM KCl was added. The sample was then monitored over a period of several 
hours to observe whether the amide resonances would emerge with longer incubation 
times. Interestingly, there was no change in the amide proton region of the NMR 
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spectrum, even at 40 hours, indicating that the lack of KCl binding was not due to slow 
kinetics, but rather the desolvation effect (Figure 3-14). 
 
Figure 3-15. 1H NMR data of amide and aliphatic regions demonstrating K+ selectivity 
of RRR-4W. Peptide sample is at 1 mM concentration in 10%D2O/NaPi buffer, pH 4.0. 
Top trace shows peptide without added salt. Middle trace shows peptide with the addition 
of 100 mM NaCl. Bottom trace shows peptide with an additional 100 mM KCl. 
 Consistent with the RRR data, RRR-4W also demonstrates selectivity for K+ in 
the presence of Na+ ions. As seen in (Figure 3-15), a 1 mM sample of RRR-4W was 
prepared in 10%D2O/NaPi buffer at pH 4.0, followed by the addition of NaCl and KCl, 
respectively. The amide proton resonances, as well as the Ala and Val peaks emerge only 
in the presence of KCl, while remaining inert towards NaCl. Previous reports on wild 
type prolinomycin indicate that a Na+ ion is too small to form a contact with all 6 
carbonyl oxygen atoms, preventing the peptide from adopting a rigid, drum-like structure. 
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The K+ ion, however, is large enough to form these contacts and can help induce the 
favorable conformation. The mutants presented above are somewhat consistent with the 
wild type data, since both RRR and RRR-4W exhibit selectivity for K+ ions, as observed 
by the signature changes in the 1D H NMR spectra. RRR also displays dynamic behavior 
and can bind and dissociate a K+ ion easily, as demonstrated by the dilution experiment in 
figure 3-6. Even more exciting is the fact that the metal-binding properties of 
prolinomycin mutants can be characterized in aqueous solution, as a result of the 
increased solubility of RRR and RRR-4W compared to the wild type peptide. This 
suggests that mutations of the non-proline side chains do not significantly alter the ability 
of the peptides to fold in the presence of K+ ions. More importantly, the peptides can still 
adopt a rigid structure under physiologically relevant conditions, making them intriguing 
synthetic candidates for biological applications. 
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3.2.3 NMR analysis of VVV peptide 
 
Figure 3-16. a) Structures of VVV and its adduct (VVV*) with 4-mercaptophenylacetic 
acid; b) ESI-MS spectrum of the purified VVV showing presence of VVV* at small 
quantities. 
 It is well established that the proline residues play a major role in the structural 
stability of prolinomycin, but not much can be inferred from the beta-branched, Val 
residues. Although they both bind K+ under physiologically relevant conditions, RRR and 
RRR9W contain only two and one Val residue, respectively, which may help them to 
adopt more dynamic behavior in water. It was hypothesized that the multiple side chain 
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mutations could potentially affect the peptides behavior relative to the wild type 
structure; thus, a mutant called VVV was synthesized to further investigate this effect. 
Due to the limitations with the proline ligation reaction, we were unable to 
synthesize a mutant that contains all Val residues. Instead, a single Val to Ala mutation 
was made at the ligation position to ensure high cyclization yields (Figure 3-16). 
However, during the ligation reaction, the free thiol formed a disulfide bond with 4-
mercaptophenylacetic acid, which we isolated via prep hplc and further analyzed by 1H 
NMR.  
 
Figure 3-17. Metal-nucleated folding of prolinomycin mutants. a) 1H NMR spectra of 
VVV with varied concentrations of K+. The peak at 6.14 ppm corresponds to maleic acid 
used as an internal standard to (0.2 mM). The peptide sample was prepared at 0.2 mM in 
10% D2O in 1:1 CD3OH: NaPi, pH 4.0. 
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 The NMR data for VVV demonstrated a similar phenomenon to RRR and 
RRR9W, in which the amide proton resonances begin to emerge at increasing 
concentrations of K+ ions (Figure 3-17).  
 
Figure 3-18. Metal-nucleated folding of prolinomycin mutants. Titration curve generated 
by plotting the peak integration at 7.35 ppm against KCl concentration.  
Surprisingly, VVV exhibited a similar Kd value (5 mM) to the other mutants, as 
assessed by plotting the integration of a single peak versus the KCl concentration, which 
demonstrates that mutations to the Val residues do not significantly affect the peptides 
ability to bind potassium (Figure 3-18). As a result, it can be assumed that the beta-
branched side chains do not significantly contribute to structure as much as the proline 
residues. Moreover, all prolinomycin analogues that were analyzed are still able to bind 
potassium at physiologically relevant concentrations, indicating that the scaffold is 
tolerant to multiple side chain mutations without compromising its metal-induced folding 
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effect. This opens up the potential for designing prolinomycin mutants with diverse 
functions for future biological applications. 
 
3.2.4 NMR analysis of dethiolated RRR peptide 
 
Figure 3-19. Wild type prolinomycin (left) and VVV analogue containing a Val to Ala 
mutation and a thiol from the ligation (right). 
Although VVV, RRR and RRR-4W exhibit very similar behavior in water, there 
is a still a significant discrepancy between the reported Kd value of wild type 
prolinomycin and the experimentally determined Kd value of our mutants. The mutants 
presented above contain two fundamental structural differences from wild type 
prolinomycin (Figure 3-19). First, prolinomycin displays 6 Val residues within its 
sequences, whereas VVV has only five, leaving a single Ala residue. Specifically, the Val 
to Ala mutation could offer more flexibility to the structure, allowing the peptide to adopt 
lower energy conformers in its uncomplexed form. This, in turn, would lower its affinity 
for K+ under physiological conditions because there would be less of a driving force to 
complex the metal. If this phenomenon were true, then we would expect to see worse 
binding for RRR and RRR-4W in comparison to VVV. Since the experimentally 
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determined Kd value for VVV and RRR are similar in the low mM range, it seems that 
mutations to non-proline residues do not seem to have a significant impact on metal 
binding.  
 
Scheme 3-3. Raney nickel reduction of RRR to remove the thiol. 
The second fundamental difference between wild type prolinomycin and the 
structural analogues is the presence of a thiol on one proline residue, which may cause 
the peptide to adopt alternative conformations that would affect its ability to fold. To test 
this hypothesis, RRR was subjected to the raney nickel reduction conditions to yield the 
dethiolated cyclic peptide in decent yields (Scheme 3-3). After RP-HPLC purification, a 
sample of the peptide, called RRR-SH, was prepared at a 0.2 mM concentration in 10% 
D2O in a 1:1 mixture of CD3OH and NaPi buffer at pH 4.0. A KCl titration was 
performed by NMR spectroscopy to directly compare the Kd values of RRR versus RRR-
SH. 
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Figure 3-20. 1H NMR KCl titration of RRR-SH in 10% D2O in 1:1 CD3OH: NaPi, pH 
4.0. 
Unfortunately, during the KCl titration assay, the NMR spectrum showed no 
distinct changes, especially in the amide proton region, indicating that K+ does not 
stabilize the peptide (Figure 3-20). Our next approach was to evade the proline ligation 
reaction altogether and synthesize the peptide through a side-chain immobilized on-resin 
head to tail cyclization strategy. Unfortunately, due to the harsh coupling conditions, 
several isomers of the peptide were isolated, making it difficult to determine which one 
possessed the correct stereochemistry. Given these challenges, it was impossible to assess 
the effect of K+ on the dethiolated peptides; thus, further investigations into the Kd value 
discrepancy between prolinomycin and its mutants will be needed in the future. 
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3.2.4 Vesicle-based titration assay to assess metal selectivity 
 
Figure 3-21. Illustration of K+-assisted folding of RRR and binding to anionic 
membranes.  
1H NMR spectroscopy of the prolinomycin mutants revealed that K+ ions induce a 
favorable conformational change to the peptides under physiologically relevant 
conditions. Some of the characteristic signatures include the emergence of amide proton 
resonances with increasing KCl concentration, as well as the sharpening of the doublets, 
which correspond to Val and Ala residues in the aliphatic region of the spectrum. More 
importantly, this phenomenon occurs exclusively in the presence of KCl, as the addition 
of an equal concentration of NaCl renders the peptide inert. 2D NMR experiments also 
revealed that in the presence of KCl, interactions between the α proton of Arg and the 
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side chain of Val occur, which is consistent with the β-turns observed in the crystal 
structure of wild type prolinomycin. 
Overwhelming evidence from the NMR studies suggests that in the presence of 
K+ ions, prolinomycin mutants can adopt a rigid conformation under physiological 
conditions in a similar manner to the wild type peptide. It was hypothesized that the 
mutants could also display analogous behaviors in the presence of a target, such as a 
membrane. For example, RRR would bind K+, forcing the cyclic peptide to adopt a rigid 
conformer that helps to display the non-proline side chains in a specific direction (Figure 
3-21). This metal-induced folding effect could then enhance the ability of the peptide to 
bind a target with high potency.  
 
Scheme 3-4. Fluorescein labeling of cyclic peptide. 
We chose to assess the activity of the prolinomycin mutants towards model 
membrane systems using a fluorescence anisotropy assay. The cyclic peptides easily were 
labeled using fluorescein-5-iodoacetamide in the presence of TCEP and a mild base, N-
methyl morpholine, in DMF (Scheme 3-4). The labeling was complete in less than an 
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hour and the resulting peptides were purified by RP-HPLC for further analysis. Peptide 
masses can be found in table 3-2 below. 
 
Table 3-2. Sequences and masses of fluorophore-labeled cyclic peptides 
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Figure 3-22. Titration experiments highlighting the differential effects between KCl and 
NaCl on RRR to partition into membranes. SUV’s were used. 
 Although not an optimal model membrane, vesicles can be formulated to contain 
precise compositions of lipids, which can provide information on how selective each 
peptide is for a given membrane lipid. We hypothesized that prolinomycin mutants would 
fold into a “drum-like” structure in the presence of K+, ultimately allowing the peptide to 
display its side chains in a preorganized manner for target binding. Consistent with the 
NMR data, RRR partitions towards anionic membrane surfaces in the presence of KCl, 
while NaCl induces no effect, as assessed by the in vitro vesicle-based assay (Figure 3-
22). Although this experimental set-up does not allow the direct measurement of metal 
chelation to the peptide, it can be assumed that RRR adopts a structure similar to 
prolinomycin under these conditions, which helps it to bind the membrane target. More 
interestingly, the cationic nature of RRR allows it to remain selective for the anionic 
lipid, PG, which is a key feature of bacterial cell membranes, while little to no binding is 
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observed towards PC, which is found predominantly on the surface of mammalian cell 
membranes. 
 
3.2.4 Vesicle-based titration assay to study side chain preorganization 
                 
Figure 3-23. K+-dependent membrane binding of the prolinomycin mutants. Comparison 
of the K+-induced membrane binding of several prolinomycin mutants. 
After establishing that RRR remains selective towards anionic membranes 
exclusively in the presence of K+ ions, we sought to carry out a mechanistic investigation 
to study how the mutants interact with the membrane. RRR-4W contains three Arg 
residues on one deck of the peptide, similar to RRR but also contains a Val to Trp 
mutation on the opposite deck. It was initially hypothesized that the introduction of an 
aromatic side chain on the opposite deck could act as a membrane insertion motif, 
rendering the sequence more potent than RRR. On the contrary, RRR-4W exhibited 
nearly the exact behavior towards anionic lipids as RRR, indicating that a mutation at the 
position has little to no effect on the binding affinity (Figure 3-23). Perhaps more 
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interesting, however, is the VRR-4R mutant, which displays the exact amino acid 
composition of RRR, except one of the Arg residues is located on the opposite deck of 
the peptide. This permutated sequence displayed surprisingly lower affinity towards 
anionic membranes at higher concentrations of K+. One explanation could be that a high 
concentration of K+ ions screens out the interactions between VRR-4R and the 
membrane, again, reinforcing that the cooperative action of all side chains on the 
prolinomycin scaffold are required for potent target binding. 
To further test the mechanism of membrane interaction, two additional mutants 
were synthesized containing a hydrophobic residue on the same face as the Arg. 
Interestingly, both RRBip and RRNp2 displayed the highest observed anisotropy values 
in this library of peptides, indicating that the preorganization of side chains on the same 
face of the scaffold is critical for potent target binding (Figure 3-24). However, the 
membrane-binding activity seemed to be independent of the salt in solution, indicating 
the hydrophobic anchors of the peptides are dominating their membrane binding 
behavior.  
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Figure 3-24. RRR linear control peptide (100 nM) binding to SUVs (250 µM) with 
increasing amounts of NaCl (left) and KCl (right) added. 
 During the proline ligation reaction, a small amount of the Nbz linear peptide 
hydrolyzes and can be isolated during the RP-HPLC purification step. After fluorophore 
labeling, the peptide was subjected to the anisotropy experiment to assess whether the 
sheer amino acid composition in solution displays any activity towards anionic 
membranes. Not surprisingly, the linear RRR was inactive against vesicles containing 
any lipid composition, indicating that the Arg residues are only effective binders when 
efficiently preorganized in a specific manner on the scaffold (Figure 3-25).  
 
3.2.4 Bacterial cell staining of RRR mutant 
The vesicle-based assay, in combination with the NMR experiments, suggests that 
the prolinomycin mutants behave quite well under physiological conditions. The ability 
of the peptide to remain selective for K+ ions under both experimental conditions further 
supports the claim that introducing side chain mutations at the non-proline residues does 
not negatively impact the folding behavior. Moreover, this folding behavior helps the 
peptides to become effective and potent receptors for a membrane target in water. At this 
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point, we were interested in examinining whether this phenomenon remains true on cell 
surfaces.
 
Figure 3-25. Flow cytometry results for RRR at concentrations of 100 nM, 250 nM, 500 
nM and 1000 nM (left to right). 
Despite the high selectivity for RRR to bind anionic model membranes in the 
presence of K+ ions, the peptide was unable to partition into bacterial cell membranes. 
This is not surprising, given that the high membrane curvature of SUV’s can generally 
illicit stronger receptor-ligand interactions due to the exposure of hydrophobic pockets on 
the membrane surface. This intrinsic property of SUV vesicles offers the extra driving 
force, which helps otherwise weak binders to be more active towards a target (Figure 3-
26). 
  
	   101	  
3.2.5 Design of hydrophobic mutants of cell staining 
 
Scheme 3-5. Synthesis of hydrophobic mutants using on resin coupling strategy. 
   
We decided to revise the sequence to include mutations with higher LogP values 
in order to maximize the hydrophobic driving force for binding. As demonstrated in 
Scheme 3-5, both an octylbenzyl and terphenyl functional group was incorporating on to 
RRR using an on resin coupling strategy, in which an alloc protected Lys residue was 
incorporated in lieu of one Arg. After synthesis of the linear sequence, the Lys can be 
orthogonally deprotected and coupled to either the 4-octylbenzyl or terphenyl acid 
deriavtives to afford the linear peptide, which would then be globally deprotected and 
cleaved from resin, then subjected to the proline ligation reaction to afford the cyclic 
peptide. We chose to install these specific hydrophobic moieties based on their relatively 
high LogP values compared to Bip, which exhibited low activity in the cell-based assays. 
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Additionally, the structural diversity between a terphenyl and an octylbenzyl residue 
would also provide more insight into the mechanism of binding.  
 
Figure 3-26. K+-dependent staining of S. aureus cells by prolinomycin mutants. a) 
microscopy results showing cell staining only in the presence of K+; (A) Phase contrast 
with no salt; (B) FITC channel with no salt; (C) Phase contrast with 30 mM KCl; (D) 
FITC channel with 30 mM KCl. 
As assessed by fluorescence microscopy, the two mutants, called RR(ObK) and 
RR(TpK), were able to partition into S. aureus cell membranes exclusively in the 
presence of K+ ions, while little to no staining was observed in the absence of the salt 
(Figure 3-28). Moreover, even though both mutants displayed similar LogP values, the 
aliphatic chain seemed to help RRR partition much better onto bacterial cells than the 
aromatic residue. 
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Figure 3-27. Flow cytometry results showing that the bacterial cell staining by RR(ObK) 
and RR(TpK) is enhanced by the addition of KCl. 
 
              
Figure 3-28. Flow cytometry histograms showing K+-dependent staining of S. aureus 
cells by prolinomycin mutants at increasing peptide concentrations. (a) RR(ObK) no salt; 
(b) RR(ObK) + KCl; (c) RR(TpK) no salt; (d) RR(TpK) + KCl. 
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The results were further confirmed by flow cytometry analysis. Plotting the 
fluorescence intensities versus peptide concentrations generates a plot which suggests 
that RR(ObK) is the most active mutants, staining S. aureus cells at low nanomolar 
concentrations, exclusively in the presence of K+ ions (Figure 3-29).  The enhanced 
staining of RR(ObK) in the presence of KCl is further exemplified by the histograms 
(Figure 3-30). 
 
Figure 3-29. Co-culture demonstrating the K+-dependent staining of S. aureus cells by 
RR(ObK) in the presence of Jurkat cells. 
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 Additionally, the peptide RR(ObK) demonstrated superb selectivity for bacterial 
cells over mammalian cells, while remaining active only in the presence of KCl, as seen 
with the co-culture microscopy experiment (Figure 3-31). Collectively, these results 
demonstrate that the metal-induced folding of prolinomycin mutants help induce a 
favorable structure for target binding, as seen with the NMR, anisotropy and cell-based 
assays. Additionally, the selective behavior of the cationic sequences in the presence of 
KCl demonstrates that more elegant receptors can be designed for target binding in the 
future.  
 
3.3 Conclusion 
 Overall, we’ve demonstrated that wild type prolinomycin is tolerant to side chain 
mutations of the non-proline residues and is synthetically accessible through the 
optimized proline ligation protocol. A thorough NMR analysis of several prolinomycin 
sequences suggests that this scaffold is tolerant to chemical modification of the side chain 
residues. Moreover, the mutants display very similar behavior in the presence of K+ ions, 
suggesting that these peptides behave well under physiologically relevant conditions. 
This has been demonstrated by an in vitro, vesicle-based assay, which shows that the 
cationic RRR and its analogues remain selective for anionic membrane lipids, as well as a 
cell-based assay demonstrating their selectivity towards bacterial cell membranes. We 
hope that this scaffold will be a powerful tool to carry out a number of biologically 
relevant applications. 
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Experimental Procedures 
 
I. General Methods 
Dawson Dbz resin and HBTU were purchased from Novabiochem (San Diego, CA). 
Boc-cis-4-hydroxy-L-proline and all Fmoc-protected amino acids were purchased from 
Chem-Impex Int’l (Wood Dale, IL). Alexa Fluor 488 C5 maleimide was purchased from 
BD Biosciences (Chicago, IL). Fluorescein-5-iodoacetamide was purchased from Marker 
Gene (Eugene, OR).  The phospholipids were purchased from Avanti Polar Lipids 
(Alabaster, AL). Methanol-d3 was purchased from Acros Organics (Geel, Belgium) and 
all other NMR solvents were purchased from Cambridge Isotopes (Tewksbury, MA). 4-
nitrophenylchloroformate, 4-mercaptophenylacetic acid and all other chemicals were 
purchased from Sigma Aldrich (St. Louis, MO). Peptide synthesis was carried out on a 
Tribute peptide synthesizer (Protein Technologies, Tuscon, AZ). HPLC purification of 
peptides was carried out on a Waters 2489 Prep-LC System (Milford, MA). 1H NMR data 
were collected on a VNMRS 500 MHz NMR spectrometer (Varian NMR Inc.) and LC-
MS data were collected on an Agilent 1260/6230 LC-MS (Agilent Technologies, Santa 
Clara, CA). Peptide concentration measurements were performed on a Nanodrop 2000c 
Spectrophotometer (Thermo Fisher Scientific, Waltham, MA).  
 
II. Peptide synthesis and characterization 
 N-Boc-(2S,4R)-tPro(Trt)-OH was synthesized according to a reported procedure. 
The prolinomycin linear precursor peptides were synthesized through Fmoc/tBu 
chemistry using the preloaded Dawson Dbz resin (3-(Fmoc-amino)-4-aminobenzoyl AM 
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resin, Novabiochem) as the solid support. The syntheses were carried out on a 0.05 
mmole scale with 5 equivalents of the Fmoc-protected natural amino acids used for the 
coupling reaction. Incorporation of N-Boc-(2S,4R)-tPro(Trt)-OH was accomplished 
using 2 equivalents of the unnatural amino acid at an extended coupling time of 2 hours. 
RR(TpK) and RR(ObK) mutants were synthesized by incorporating Fmoc-Lys(alloc)-OH 
in place of Fmoc-Arg(Pbf)-OH, followed by orthogonal deprotection of the alloc group 
using a mixture of 60 mg tetrakis(triphenylphosphine)-palladium (Pd(PPh3)4) and 0.3 mL 
phenylsilane in 2 mL dichloromethane. The coupling step was accomplished using 
HBTU (1 equivalent) to activate either p-Terphenyl-4-carboxylic acid or 4-Octylbenzoic 
acid to afford the RR(TpK) and RR(ObK) linear peptides, respectively. Conversion of the 
Dbz resin to the Nbz moiety was accomplished by mixing the resin with 5 equivalents of 
4-nitrophenylchloroformate in DCM (3mL) for 1 hour, followed by 20 min incubation 
with 3 mL of 0.5 M NMM in DMF. The peptides were cleaved off the resin and globally 
deprotected with reagent K (80% TFA, 5% H2O, 2.5% EDT, 5% thioanisole and 7.5% 
phenol). The crude peptides were found to display good purity and directly subjected to 
the proline ligation reaction without purification. 
The proline ligation reaction was accomplished by dissolving the crude, linear peptide 
(2-5 mM) in a mixture of DMF and ligation buffer (0.2 M sodium phosphate, 3 M 
guanidinium chloride, 20 mM 4-mercaptophenylacetic acid, pH 8) and allowing the 
reaction to proceed overnight. Upon completion of the reaction, judged by LC-MS 
analysis, the reaction was acidified with Buffer A (0.1% TFA in H2O) and then purified 
by RP-HPLC (Waters Prep LC, Jupiter C18 Column) to afford the cyclic peptide in 40-
50% yields (calculated against the crude peptide mass). According to LC-MS analysis, all 
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peptides except the VVV mutant displayed high purity (>95%) and clean mass-spec data 
that correspond to the desired product. The VVV peptide after purification showed a 
small amount of disulfide adduct with 4-mercaptophenylacetic acid. This material was 
subjected to NMR analysis without further purification as the adduct formation is not 
expected to interfere with the K+ binding behavior of the peptide. 
 
III. NMR characterization of prolinomycin mutants 
All peptide samples for NMR analysis were prepared in a 1:1 mixture of CD3OH and 
50 mM sodium phosphate buffer, pH 6.0 with overall 10% D2O by volume. Peptide 
concentrations were 0.2 mM and an internal standard (maleic acid) was included in each 
sample at a concentration of 0.2 mM. 1H NMR spectra of the prolinomycin mutants were 
collected on a Varian INOVA 500 MHz NMR spectrometer. Water suppression was 
accomplished using a PRESAT experiment to purge and subtract the water peak.  
For the salt titration experiment, NMR spectra were recorded after sequential addition 
of KCl into the sample. The metal-reversibility experiment was accomplished by adding 
5 mM KCl to a 2 mM peptide (and 2 mM maleic acid) sample, followed by a 10 x 
dilution to 0.5 mM KCl and 0.2 mM peptide. NMR data were processed using 
MestReNova (Mestrelab Research S. L., Spain).  
 
 
 
 
 
	   109	  
IV. Synthesis of fluorophore-labeled peptides 
The fluorescein conjugates of the prolinomycin mutants were synthesized using 
fluorescein-5-iodoacetamide (Marker Gene, Eugene, OR) as the labeling reagent. The 
peptide (1 mg) was dissolved in 300 µL of DMF and TCEP (7.5 µL of a 100 mM stock in 
H2O) was added to reduce any disulfide bonds. N-methylmorpholine (20 µL) and 
fluorescein-5-iodoacetamide (150 µL of a 5 mM stock in DMF) were added and the 
reaction was left to sit in the dark for 1 hour.  The reaction was diluted with Buffer A 
(0.1% TFA in H2O) and purified by RP-HPLC (Waters Prep LC, Jupiter C18 Column). 
Alexa Fluor 488 (AF488) labeling of the peptides was accomplished by following a 
similar protocol with AF488 C5 maleimide (100 µL of a 1 mM stock in DMF) as the 
labeling reagent. The fluorescein and AF488 labeled peptides were confirmed by LC-MS.  
The linear control peptide, RRR-OH was synthesized through hydrolysis of the 
Nbz RRR linear precursor. The crude peptide was dissolved in 2 M NaOH and allowed to 
sit overnight. The sample was lyophilized and directly labeled with fluorescein-5-
iodoacetamide, following the protocol stated above. The peptide was purified by RP-
HPLC (Waters Prep LC, Jupiter C18 Column) and the purity and mass confirmed by LC-
MS. 
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V. Vesicle binding assay using fluorescence anisotropy 
Small unilamellar vesicles (SUVs) were prepared by dissolving the desired 
phospholipids in chloroform, then mixing the stocks to get the desired ratios. Chloroform 
was evaporated and the lipid mixtures were re-suspended in 50 mM Tris buffer, pH 7.4 
and left to sit for 1 hour. The lipid suspensions were ultra-sonicated using a 20 second 
pulse for 20 minutes, then filtered. The Steward assay was used to determine the 
concentrations of the resulting liposome stocks. This is a colorimetric method that is 
based on the complex formation between phospholipids and ammonium ferrothiocyanate. 
Briefly, 2 mL of 0.1 M NH4Fe(SCN)4 in aqueous solution was added to 2 mL of 
chloroform containing a small volume of the phospholipid stock. The resulting mixture 
was vortexed for 1 min and then centrifuged at 5,000 rpm for 5 min. The UV absorption 
of the chloroform layer containing the phospholipids was measured at 465 nm and the 
concentrations of the vesicles were calculated using the reported extinction coefficient of 
PC (7960 M-1cm-1). 
 
VI. Vesicle binding assay using fluorescence anisotropy 
Stock concentrations of fluorescein-labeled peptides were measured by recording the 
UV-Vis absorbance at 495 nm (ε = 80,000 M-1 cm-1). Fluorescence anisotropy 
experiments were carried out on a Cary Eclipse Spectrophotometer (Agilent 
Technologies) with a 10 mm path length quartz cuvette. A G factor of 1.4213 was 
calculated for fluorescein prior to the titration experiments. The fluorescein-labeled 
cyclic peptides were dissolved in DMF to give a 1 mM stock, which was diluted (with 50 
mM Tris buffer, pH 7.4) to 100 nM peptide concentration for the vesicle binding 
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measurement. The samples were excited at 493 nm and their emissions were monitored at 
520 nm to generate the anisotropy values. Metal dependence was measured by titrating 
increasing amounts of NaCl or KCl to a peptide sample containing 250 µM SUV’s, while 
membrane binding was assessed by adding increasing amounts of SUV’s into a peptide 
sample containing 20 mM salt. Anisotropy values were plotted against liposome or salt 
concentrations to generate the binding curves.  
 
VII. Cell culture experiments 
Stock concentrations of the AF488-labeled peptides were measured by recording the 
UV-Vis absorbance at 495 nm (ε = 80,000 M-1cm-1).  
 
Staphylococcus aureus Cells 
Staining of Staphylococcus aureus bacteria by AF488-labeled cyclic peptides was 
assessed using flow cytometry and fluorescence microscopy. Bacteria from a single 
colony were grown overnight in LB broth at 37 °C with agitation. An aliquot was taken 
and diluted 100 times in fresh broth and sub-cultured for 3 hours until the cells reached 
OD600 of 1.0. The bacterial cells (200 µL) were centrifuged, re-suspended in 4 mL of Tris 
buffer (50 mM Tris base, pH 7.4), then an aliquot (100 µL) was mixed in with peptide 
samples at 100, 250, 500 and 1000 nM concentrations. 30 mM KCl was added to each 
peptide sample in a separate batch to assess binding in the presence of salt. The flow 
cytometry experiments were carried out on a BD FACS Aria cell sorter (BD Biosciences, 
San Jose, CA) and the data analysis was performed with FlowJo (Tree Star, Inc., 
Ashland, OR) and Origin (OriginLab Corp., Northampton, MA).  
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Microscopy samples were prepared using a similar protocol as stated above, except 
after sub-culturing, aliquots (100 µL) of the cells were centrifuged and directly re-
suspended in 50 µL of the peptide solution (1000 nM in Tris buffer, pH 7.4). A separate 
batch of peptide samples was prepared containing 30 mM KCl each to assess bacteria 
staining in the presence of the salt. 3 µL of cells were transferred to a slide (Fisherfinest 
premium, 3”x1”x1 mm) and fixed with a cover glass (Fisherbrand, 22x22–1.5) 
Fluorescence images were taken on a Zeiss Axioplan 2 microscope equipped with filters 
that allow the detection of FITC (488 nm excitation, 515-520 nm emission) using a 100 x 
objective. All images were captured using an exposure time of 300 ms and processed in 
ImageJ following the same protocol. 
 
Jurkat Cells 
 The co-culture experiments were performed using the same protocol stated above 
for bacterial cell preparation. Jurkat cells were grown in RPMI 1640 media with 10% 
FBS and 1% Pen/Strep at 37 °C and 5% CO2 and passed for less than 20 generations. An 
aliquot (2 mL) of cells was centrifuged and directly re-suspended in 200 µL of buffer (50 
mM Tris, pH 7.4). Cell stocks were combined and the peptide was added to a 
concentration of 1 µM from a concentrated stock. A separate batch of samples was 
prepared containing 30 mM KCl in the same buffer to assess the staining in the presence 
of salt. The staining and microscopy imaging were carried out using the same protocol as 
the S. aureus cells. 
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Chapter 4. Dissecting the energetic consequences of fluorinating a protein core 
 
4.1 Introduction 
Proteins have emerged as a powerful class of therapeutic agents due to their 
superior properties over small molecules in the clinic [103]. Some of the key advantages 
include their large surface areas and highly defined structures, which allow them to 
perform very specific functions that are generally not reproducible with traditional small 
molecule scaffolds. Due to this high specificity, proteins do not generally induce adverse 
side effects in patients and they are less likely to interfere with otherwise normal 
biological processes. Additionally, since many of the proteins used in the clinic are 
already native to the body, they are better tolerated as drugs and are less likely to elicit an 
immunological response [104]. 
The ability of a protein to properly fold is an essential part of life. These 
macromolecules rely on the precise, non-covalent molecular interactions between their 
specific side chain residues to achieve a desired 3-dimensional structure. Remarkably, 
nature can accomplish this using only the 20 natural amino acids with commonly 
observed interactions including hydrogen bonding, salt bridges and hydrophobic 
interactions. Although these elements work cohesively to help the protein adopt a well-
defined structure, it is thought that the latter interaction plays a rather significant role in 
protein stabilization. A survey of the protein data bank reveals that aromatic clusters are 
prevalent in protein structures with around 60% of aromatic side chains forming a close 
contact with another aromatic residue [105]. These interactions are often found buried 
within a hydrophobic core and until now have been difficult to study since side chain 
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mutations at these sites will inevitably perturb several factors at a time. While it is 
thought that these interactions play a key role in helping a protein to fold, it is difficult to 
introduce a mutation at this site without perturbing the overall structure.  
 
4.1.1 Contribution of fluorine in protein design  
Fluorination is an increasingly sought after strategy in protein engineering due to 
its small size, high electronegativity and of course, its absence from biological systems 
[106, 107]. It is the most electronegative atom, displaying highly unique electrostatic 
properties, while its small size renders it analogous to a hydrogen atom (1.35 Å for F and 
1.2 Å for H). The result is that a fluorine atom will introduce minimal steric perturbation, 
an important quality to consider when attempting to not only maintain a protein structure, 
but also to further enhance it. Additionally, fluorocarbons display superior hydrophobic 
properties while also exhibiting selective self-association behaviors with other fluorinated 
molecules [108]. Its absence from biological systems also offers a great opportunity to 
selectivity trace a fluorine atom in both cells and in living organisms with little to no 
background [109]. Some of the few methods used to accomplish this include 19F NMR 
spectroscopy, which can be a powerful tool to analyze a protein structure, as well as its 
interaction with a target [110]. Other methods include positron emission tomography 
(PET), which utilizes 18F as a tracer to analyze 3-dimensional images while other 
techniques, such as MRI and CT and x-ray can only provide structural information [111]. 
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Figure 4-1. Geometries of π-π interactions. Left: edge-face; middle: offset-stacked; right: 
face-face stacked. 
Taking the simplest aromatic molecule, benzene, we can begin to understand how 
they interact with one another in solution. A benzene dimer, for example, preferentially 
interacts in the edge-face manner, where the electropositive hydrogen atom of one 
benzene ring forms a contact with the electronegative π cloud of the other [112]. This 
specific orientation ensures that the two molecules adopt the most energetically favorable 
conformation. Conversely, perfluorination of a benzene molecule reverses its electrostatic 
properties, allowing it to interact in the face-face stacking geometry with a benzene ring.  
 
4.1.2 Fluorinated aromatic residues and protein stability 
To further demonstrate this fundamental principle in the context of a protein, 
Waters and co-workers incorporated steric mimics of native aromatic residues and 
analyzed their energetic properties [87]. They incorporated perfluorophenylalanine (f5F), 
which displays an electron deficient center as a result of perfluorination, into Ala-Lys to 
study the difference between F-F and F- f5F pairs and their effects on aromatic 
stabilization in α-helices. Incorporating an F-F pair at the C-terminus peptide resulted in 
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an energetic gain of -0.80 kcal/mol versus an internal position (-0.26 kca/mol), 
potentially due to the flexibility at that position, allowing side chains to reorient 
themselves and adopt a more favorable conformation. Incorporating the F- f5F pair at the 
same position resulted in a smaller energetic gain (-0.55 kcal/mol), indicating that this is 
not purely a result of hydrophobic interactions, but instead, a result of the partially 
electrostatic nature of F-F. 
The electronic and hydrophobic contributions towards aromatic packing were 
further studied with a model β-hairpin structure [113]. Examining a generic sequence, 
Ac-Arg-X1-Val-Orn-Val-Asn-Gly-Lys-Glu-Ile-X2-Gln-NH2, in which residues X1 and X2 
interact pack against one another. They incorporated either a Phe or a cyclohexylalanine 
(Cha) mutation. Although sterically similar to Phe, Cha exhibits dramatically different 
behavior in that it is electronically deficient and unable to engage in a π-π interaction. 
Interestingly, they observed that peptides containing either Phe-Phe or Cha-Cha pairs 
were comparable in stability, whereas the mixed pairs were less favorable. NMR analysis 
further supported this result by revealing a tight, edge-face geometry between the Phe-
Phe pair, reinforcing the importance of self-association when it comes to aromatic 
residues. 
Conversely, reports by Nowick and co-workers described a similar study in which 
they incorporated Phe and Cha residues into a model β-sheet template, which undergoes 
dimerization to form contacts between the R1 position from one monomer and the R5 
position from the other [114]. Interestingly, they observed that all four possible dimers 
were found to exist at equal percentages in solution. Although conflicting with earlier 
results, this is perhaps not too surprising given that a high frequency of Phe-Phe 
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interactions are generally observed in hydrogen-bonded cross strand pairs of antiparallel 
β-sheets, while this study examined a nonhydrogen-bonded cross-strand pair [115, 116]. 
 
4.1.3 Studying edge-face interactions in a model protein 
               
Figure 4-2. Structure of VHP35 hydrophobic core illustrated aromatic stacking. Figure 
adopted from reference [117]. 
These fundamental studies, although significant, have only described the 
contributions of aromatic interactions at solvent exposed positions. Since most aromatic 
interactions occur within hydrophobic pockets of protein structures, it is imperative to 
understand how these molecules behave in the context of a more relevant environment. 
The villin headpiece subdomain (VHP35) is a widely studied α-helical model peptide. 
The core consists of three interacting phenylalanine residues with the H-4 of F6 packing 
against the phenyl ring of F17, while the H-6 atom of F10 packs against the π cloud of 
F6. Earlier work described by Gellman and co-workers nicely demonstrated that 
perfluorination of side chain F10 acts to stabilize the overall protein structure, but at 
positions F6 and F17, destabilizes it [118].  
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Intrigued by these results, Gao and co-workers set out to further examine this 
event by implementing various fluorine mutations to the aromatic residues within 
VHP35’s hydrophobic core [117]. Fluorination of these side chains would render them 
more hydrophobic, but would also eliminate the critical CH- π interactions between the 
aromatic hydrogens of F6 and F10 and the π clouds of F17 and F6, respectively. It was 
proposed that highly, but not fully fluorinated analogues of these aromatic side chains 
would allow this key interaction to occur, while simultaneously introducing a 
hydrophobic driving force. Two phenylalanine analogues, called 2,3,4,5-tetrafluoro-L-
phenylalanine (Zo) and 2,3,5,6-tetrafluoro-L-phenylalanine (Zp) were synthesized and 
incorporated into VHP35 and their resulting thermal and chemical stabilities were 
compared to a perfluorinated analogue, called pentafluoro-L-phenylalanine (Z). 
Interestingly, the F10Zo mutant, which presents a fully fluorinated aromatic side 
chain with the exception of one aromatic hydrogen at the ortho position, displayed higher 
stability (-4.7 kcal/mol) in comparison to the perfluorinated mutant, F10Z (-3.6 
kcal/mol). The difference here can be rationalized by the presence of a single hydrogen 
atom at the ortho position of F10Zo, which allows it to engage in a critical CH- π 
interaction with F6. This is further supported by the F10Zp result, which also exposes a 
single hydrogen atom, but exhibits lower stabilities (-3.2 kcal/mol), even worse than the 
WT (-3.3 kcal/mol). Collectively, the results suggest that in order to be effective, a 
fluorine mutation must be incorporated with careful consideration of the surrounding 
environment. 
It is thought that the superior behavior of F10Zo could be attributed to a 
combination of factors. In the case of VHP35, the CH- π interaction between F10 and F6 
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aromatic residues contributes a great deal of stability to the protein fold. However, other 
factors, such as the hydrophobic effect, as well as the electrostatic interactions between 
atoms have not been thoroughly investigated. In an effort to further understand the 
specific contributions of a fluorine atom in the context of the VHP35 protein core, I have 
embarked on a research program to investigate how each of these factors plays a role in 
the proteins ability to fold. 
 
4.2 Studying edge-face interactions with fluorinated F10 Phe residues 
It is well established that maintaining the CH- π interaction between F10 and F6 
side chains of VHP35 results in a well-folded protein. Therefore, we focused on this 
specific aromatic pair and designed a series of amino acids containing various degrees of 
fluorination to be incorporated at the F10 position. In contrast to earlier studies where the 
aromatic side chain displayed only one hydrogen atom, we sought to carry out a more 
detailed investigation by introducing a fluorine atom at carefully selected positions and 
observing the resulting effect on the proteins structure. More specifically, we were 
interested in determining whether the free energy gain associated with a fluorine mutation 
at F10 is context dependent, or whether this phenomenon is independent of the amount of 
fluorine atoms present. 
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Figure 4-3. Series of fluorinated amino acids used to study an edge-face interaction in 
VHP35 model peptide. 
 
4.2.1 Synthesis and design of fluorinated aromatic amino acids and VHP35 peptides 
 We designed a series of amino acids that would help us to answer these questions. 
Included within this library is a set of mono-fluorinated Phe residues with a fluorine atom 
incorporated at either the ortho, meta or para position of the ring. These amino acids will 
help us to explore the chemical space within the VHP35 hydrophobic core by 
determining whether a fluorine atom is better tolerated at one position over another, or 
whether it causes steric perturbation. The di-fluorinated amino acids, ortho-2F, meta-2F 
and metapara-2F have been specifically designed to complement the mono-fluorinated 
variants, since they also occupy the ortho, meta and para positions. However, this set of 
molecules is unique in that we expect to see both an enhanced hydrophobic driving force 
with the addition of an extra fluorine atom, as well as an increased chance of steric 
perturbation. Ultimately, if the di-fluorinated analogues display no enhanced free energy 
gain, then we can contribute this loss to the unfavorable steric bulk that an extra fluorine 
atom introduces at that specific position. This does not apply, however, to ortho-2F 
mutant, since it is missing the critical aromatic hydrogen atoms to engage in a CH- π 
interaction with F6. Finally, metapara-3F, which contains the highest degree of 
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fluorination in this series, would offer insight on the potential additive effect of 
fluorination. 
 
     
Scheme 4-1. Preparation of Fmoc-2,6-difluorophenylalanine from 2,6-difluoro benzyl 
bromide. The Schöllkopf’s Chiral Auxiliary 2 was prepared according to the reported 
protocol. 
The fluorinated Phe amino acids can be accessed using a well-established 
synthetic route. Although most of the amino acids used in this study were commercially 
available, we had to synthesize the Fmoc-2,6-difluoro-L-phenylalanine in house. The 2,6-
difluorobenzyl moiety was installed onto Schollkopf’s chiral auxiliary using standard 
alkylation reaction conditions. The steric nature of the chiral auxiliary helps to direct the 
stereochemistry of the resulting product. Specifically, the beta-branched functional group 
introduces the necessary steric bulk that helps nBuLi deprotonate the least hindered 
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hydrogen atom, which is the one trans to the isopropyl group. The absolute 
stereochemistry has been confirmed by 2D-NMR experiments [119]. Following 
alkylation, the diastereomer was subjected to acid hydrolysis to break apart the ring and 
yield two amino acid derivatives, 2,6-difluoro-L-Phe and D-Val, which can be separated 
via column chromatography. Upon isolation of the desired product, intermediate 5 is 
subjected to base hydrolysis to convert the ester into the free carboxylic acid, Fmoc 
protection of the free amino acid yields Fmoc-2,6-difluoro-L-Phe in good yields, which 
was then incorporated into the VHP35 sequence via solid phase peptide synthesis.  
             
 
Scheme 4-2. Synthetic route of to access VHP35 peptide and its fluorinated mutants 
using Fmoc-Phe-Wang resin. 
Peptide synthesis was accomplished using Fmoc-Phe-Wang resin using standard 
Fmoc/tBu chemistry. Linear sequences were built until the F10 residue, at which point, 
the unnatural amino acid was incorporated and checked by LC-MS to ensure efficient 
coupling. Following completion of the synthesis, the peptides were cleaved off the resin 
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and purified using RP-HPLC. Due to the length of the sequence, some optimization was 
required to ensure that the crude peptides contained little to no truncation products, which 
would in turn facilitate the purification step. For example, there are certain residues, such 
as Arg, Val and Pro, which are more difficult to couple due to their steric bulk. To 
circumvent this problem, we opted to use HATU as a coupling reagent, which reacts 
faster and with less epimerization than HBTU does. Additionally, we increased the 
coupling time of all residues from 30 minutes to 1 hour, which greatly reduced the 
number of truncation products. Collectively, all of these factors afforded the VHP35 
peptide and its mutants in high purities and yields. 
 
Table 4-1. Mass spectrometry data for VHP35 peptide mutants  
 
 
 
 
 
 
 
 
 
 
 
 
Peptide MW calculated (Da) MW found (Da) 
WT 4082 4081 
Ortho-1F 4100 4099 
Meta-1F 4100 4100 
Para-1F 4100 4099 
Ortho-2F 4118 4117 
Meta-2F 4118 4119 
MetaPara-3F 4136 4135 
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4.2.2 Structural characterization of VHP35 mutants 
               
Figure 4-4. Wavelength scan of VHP35 mutants by CD spectroscopy 
The peptides were subjected to spectroscopic analysis using circular dichroism to 
confirm that all mutants maintained a structure similar to the WT. Wavelength scans were 
performed in the far-UV region of the spectrum and the experiments were carried out at 2 
°C to ensure that the peptides were folded. Indeed, a wavelength scan reveals an 
ellipticity minimum at 208 and 222 nm, which is indicative of α-helicity. Compared to 
WT, however, ortho-2F exhibited a very weak CD signature, suggesting that it is not well 
folded under the experimental conditions. This is not surprising due its lack of aromatic 
hydrogens at the ortho positions, which prevents it from engaging in the critical CH- π 
interaction necessary for folding. 
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4.2.3 Thermodynamic characterization and analysis of VHP35 mutants 
            
Figure 4-5. Thermal denaturation curves of VHP35 mutants generated by CD 
spectroscopy 
We investigated the thermal stabilities of VHP35 WT and its mutants by 
performing thermal denaturation experiments and monitoring the results at a wavelength 
of 222 nm via CD spectroscopy. The peptide samples were prepared in native buffer A 
and heated up at 2 °C increments until the temperature reached 98 °C. After each 2 °C 
temperature increase, the sample was equilibrated for 90 seconds before recording the 
ellipticity value. The signals were averaged for 30 seconds to ensure no variation in the 
data. Not surprisingly, all of the thermal denaturation curves displayed a sigmoidal 
transition, which was then tabulated to yield the melting temperature (Tm) values. It must 
be noted that for VHP35 and its mutants, the folding and unfolding was completely 
reversible. 
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Figure 4-6. Chemical denaturation curves of VHP35 mutants generated by GdmCl 
titration via CD spectroscopy. 
 Chemical denaturation experiments were also performed to generate ΔGf values 
for all mutants. In this experiment, CD spectroscopy was used to determine the peptides 
conformation by plotting the ellipticity values at 225 nm as a function of GdmCl 
concentration. Titrations were performed at increments of 0.2 M GdmCl and the sample 
was stirred for 30 seconds after each addition and equilibrated for 2 minutes before 
recording the ellipticity values. Thermodynamic fitting of the resulting curves using a 
standard baseline extrapolation method yielded the thermodynamic parameters listed in 
Table 4-2. 
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Table 4-2. Tabulated thermodynamic data for VHP35 mutants 
 
Protein 
 
Tm 
(°C) 
Cm 
(M) 
m value 
(kcal/(mol·M)) 
ΔGf 
(kcal/mol) 
ΔΔGf 
(kcal/mol) 
      
WT 64 3.2 0.81 -2.6 ± 0.1 0 
  
Ortho-1F 70 3.7 0.84 -3.1 ± 0.1 -0.5 ± 0.1 
  
Meta-1F 70 3.3 0.82 -2.7 ± 0.1 -0.1 ± 0.1 
      
Para-1F 74 3.9 0.76 -3.2 ± 0.1 -0.6 ± 0.1 
  
Ortho-2F 62 2.9 0.76 -2.2 ± 0.1 +0.4 ± 0.1 
      
Meta-2F 74 4.1 0.93 -3.8 ± 0.1 -1.2 ± 0.1 
Parameta-3F 70 3.4 0.88 -3.0 ± 0.1 -0.4 ± 0.1 
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4.2.5 Synthesis of fluorinated amino acids for LogP studies 
 
 
Scheme 4-3. Synthesis of acetyl capped amino acids for LogP studies 
To further understand the hydrophobic contribution of a fluorine atom, we 
embarked on a study to experimentally determine the LogP value of each fluorinated Phe 
mutant. We began by Fmoc deprotection of the amino acids, followed by acetylation 
using acetic anhydride. After prep-HPLC purification, the molecules were dissolved in an 
acidic Gly buffer (pH 2) to ensure that they would remain neutral for the subsequent 
LogP determination.  
 
Table 4-3. Mass spectrometry data for acetylated amino acids 
Molecule MW calculated (Da) MW found (Da) 
Ac-Ortho-1F-OH 224.08 224.0785 
Ac-Meta-1F-OH 224.08 224.0757 
Ac-Para-1F-OH 224.08 224.0754 
Ac-Ortho-2F-OH 242.06 242.0672 
Ac-Meta-2F-OH 242.06 242.0761 
Ac-MetaPara-3F-OH 260.06 260.0606 
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To calculate the octanol to water partition coefficients, the samples containing 
each molecule in a Gly buffer were added to an equal volume of octanol and mixed and 
allowed to sit for 15 mins at room temp. Following complete separation, an aliquot of 
each layer was extracted and injected into the LC-MS to determine the resulting 
concentrations and the values were used to calculate the LogP values (Table 4-4).  
 
Table 4-4. Calculated LogP results of VHP35 mutants 
Mutant Trial Trial 2 
Phenyl 4.27 4.44 
Ortho-1F 4.88 4.72 
Meta-1F 3.78 3.84 
Para-1F 3.58 3.78 
Ortho-2F 4.01 4.67 
Meta-2F 10.22 11.91 
Metapara-3F 20.62 23.03 
 
 
Figure 4-7. Comparison of monofluorinated F10 mutants. 
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We began our analysis by focusing on the monofluorinated mutants, ortho-1F, 
meta-1F and para-1F. By introducing a single point mutation at each position of the 
aromatic ring, we expect to determine the steric contribution of a fluorine atom within the 
hydrophobic core of VHP35. Not surprisingly, all three mutants exhibit similar logP 
values, indicating that if the hydrophobic driving force is a significant event in helping 
the protein to fold, then all three mutants contribute equally. Compared to WT, which 
displays a ΔG value of -2.6 kcal/mol, both ortho-1F and para-1F introduce an additional 
0.5 kcal/mol and 0.6 kcal/mol, in binding free energy, respectively. If we further dissect 
the structural differences between ortho-1F and para-1F, we remember that the presence 
of an ortho hydrogen atom is crucial for maintaining the CH-π interaction with the F6 
side chain. Although both peptides are capable of engaging in this interaction, ortho-1F 
contains a fluorine atom at one of those positions, which we expect will force the 
aromatic ring to discriminate between one orientation over another. Para-1F, however, is 
expected to be more dynamic and perhaps require more energy to fold. The 
thermodynamic data suggests that both peptides contribute equally in folding free 
energies, thus, blocking a site of interaction does not bias the structure in a favorable 
way. On the other hand, Meta-1F displays a nearly identical free energy value to WT, at -
2.7 kcal/mol. Although it displays a similar LogP value to the other monofluorinated 
mutants, we hypothesized that the fluorine atom may present itself on the F10 ring in an 
unfavorable orientation where it is involved in a steric or electronic repulsion with 
another atom in the core. Another possibility could be that a fluorine atom at the meta 
position is inert, while at the ortho and para positions is favorable. 
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Figure 4-8. Comparison of mono and difluorinated mutants at the ortho position of F10. 
 Perhaps even more obvious is the difference between mutant’s, ortho-1F and 
ortho-2F. We expect to see no benefit of an extra fluorine atom at the ortho position of 
F10, since we would essentially be eliminating any possibility of a CH-π interaction. The 
thermodynamic results agree, as ortho-2F exhibited the poorest free energy value in this 
series, nearly 0.5 kcal/mol worse than the WT. If we recall the previous studies done in 
our group comparing F10Z and F10Zo, we remember that the former is also not capable 
of engaging in a CH-π interaction, since every hydrogen atom on F10 has been replaced 
with fluorine. However, compared to the WT, F10Z exhibited a slightly favorable 
binding free energy value (ΔΔG = -0.3 kcal/mol), indicating that perfluorination may 
offset the negative impact of removing the CH-π interaction. Ortho-2F displays only two 
fluorine atoms, which may not be enough to compensate this effect. 
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Figure 4-9. Comparison of ortho and di fluoro mutants at the meta position. 
The previous example is not appropriate for evaluating the additive effect of 
fluorination because one of the mutants completely abolishes the critical CH-π interaction 
that is a huge driving force for VHP35 folding. To circumvent this problem, we chose to 
analyze two mutants, meta-1F and meta-2F, which both expose these critical ortho 
hydrogen atoms. Meta-2F (-3.8 kcal/mol) displays far superior free energy values 
compared to meta-1F (-2.7 kcal/mol), which we attribute to the huge discrepancy in LogP 
values (10.22 vs. 3.78). In this case, we can argue that the hydrophobic effect is a huge 
contributing factor, which may have offset the potentially negative steric and electronic 
repulsion effects that meta-1F displayed in comparison to the other monofluorinated 
mutants. This could be a lesson to demonstrate how a mediocre mutant, such as meta-1F 
can transform into one of the best and most stable proteins candidates by the addition of a 
single fluorine atom at a carefully place position. In terms of protein engineering, this 
result validates the potential of using a fluorine atom as a directing group. 
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Figure 4-10. Comparing the additive effect of fluorination in VHP35 
 We attempted to take it a step further and examine whether the best mutant, meta-
2F could be engineered even further to display an even more favorable folding free 
energy value. Based on previous results, we’ve shown that blocking a single ortho 
position with a fluorine atom does not favor one conformer over another, so we focused 
on introducing the additional fluorine mutation at the para position, yielding metapara-
3F. Interetsingly, metapara-3F displayed the highest LogP value in the entire library, but 
its folding free energy was mediocre (-3.0 kcal/mol). In fact, meta-2F, which has nearly 
half the LogP value of metapara-3F, is nearly 1.0 kcal/mol more stable. This result 
demonstrates how there may be a very intricate mechanism within the VHP35 
hydrophobic core where simply enhancing the hydrophobicity of F10 is not enough to 
enhance the folding properties. 
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4.2.6 19F NMR analysis of ortho-2F and meta-2F peptides 
 
Figure 4-11. 19F NMR data of ortho-2F and meta-2F demonstrating temperature induced 
denaturation. 
 Thermodynamic characterization of the peptide library allowed us to compare the 
subtle difference between each mutant upon fluorination of the F10 residue. We can 
rationalize the differences based on a number of factors including, but not limited to, 
hydrophobicity, steric bulk and of course, the presence of a CH-π interaction. We were 
interested in going a step further and analyzing the best and worse mutants at the atomic 
level via 19F NMR spectroscopy. We subjected ortho-2F and meta-2F to a temperature 
gradient experiment and compared the resulting spectra to one another. Consistent with 
both thermal and chemical denaturation data, ortho-2F seems to display multiple 
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conformers at room temperature, suggesting that the fluorine atoms are not well tolerated 
at the ortho positions of F10. However, with an increase in temperature, we expect the 
peptide to denature, until it reaches a fully unfolded state. It’s not until we reach the 
maximum temperature at 80 °C, that we observe the presence of a single conformer, 
which we assume to be in the fully unfolded state. 
 On the other hand, meta-2F, which is the most stable mutant in the library, seems 
to adopt one major conformer at room temperature, which we presume is the fully folded 
one, while the smaller peaks can be attributed to the presence of a small percentage of 
conformers. As the temperature increases, we observe that the smaller conformers begin 
to coalesce into the larger peak until it reaches its fully denatured state at 80 °C. One 
critical difference between these two mutants is that meta-2F displays one major 
conformer at every temperature, indicating that the peptide is indeed well folded, while 
ortho-2F seems to adopt multiple conformers, never displaying a major conformer until 
the peptide is fully denatured.  
 
4.3 Conclusions 
 To conclude on this model, we have demonstrated that fluorine atoms are well 
tolerated, and in some cases, even favorable at certain position of F10. The exception is a 
mutation at both ortho positions (ortho-2F), where the edge-face interaction is not 
existent. In terms of steric tolerance, it seems that the contribution of a fluorine atom at a 
single meta position, meta-1F, does not introduce any benefit, while at the ortho and para 
positions, contributes nearly 0.5 kcal/mol in enhanced free energy values. The most 
interesting result, however, suggests that a poorly folded peptide, such as meta-1F, can be 
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transformed into an extremely stable mutant with the addition of a single fluorine atom at 
a carefully placed position, as demonstrated with meta-2F. Although originally 
rationalized to be a result of the added hydrophobic driving force, we have proven that 
adding even more hydrophobicity to the best mutant, which yield metapara-3F, does not 
further enhance the folding free energy values. In fact, it destabilizes the structure by 
nearly one full kcal/mol.  
Finally, 19F NMR spectroscopic analysis reveals that peptide conformers can be 
studied in solution at various temperatures to determine their stabilities. We’ve compared 
the best (meta-2F) and worst (ortho-2F) mutants and shown that the former maintains a 
well-defined structure at various temperatures, whereas the latter displays a bunch of 
conformers, only collapsing into the fully denatured, major one at high temperatures. 
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Experimental Procedures 
 
I. General Methods 
Fmoc-Osu and HBTU were purchased from Novabiochem (San Diego, CA). All 
Fmoc-protected of acetyl-protected amino acids were purchased from Advanced 
Chemtech (Louisville, KY) or Chem-Impex (Wood Dale, IL). All other chemicals were 
obtained from Fisher Scientific or Sigma Aldrich unless otherwise indicated. Peptide 
synthesis was carried out on a Tribute peptide synthesizer (Protein Technologies, Tucson, 
AZ). 1H and 13C NMR measurements for the amino acids were performed on a Varian 
INOVA 500 MHz spectrometer. 19F NMR measurements of the peptides were taken on a 
Varian INOVA 600 MHz spectrometer. HR-MS data were generated in house by the 
Boston College Mass Spectrometry Center. Circular dichroism measurements were 
performed on an AVIV CD spectrometer (Aviv Biomedical Inc. Lakewood, NJ). The 
LogP calculations were performed on an Agilent LC-MS (Agilent Technologies, Santa 
Clara, CA) in house. The peptide concentrations were determined on a Nanodrop 2000c 
Spectrophotometer (Thermo Fisher Scientific, Waltham, MA).  
 
II. Synthesis of Fmoc-N-2,6-difluorophenylalanine  
(2S,5R)-2-(2,6-difluorobenzyl)-3,6-diethoxy-5-isopropyl-2,5-dihydropyrazine (3).  In 
a flame dried round bottom flask equipped with a magnetic stir bar under N2, compound 
2 (630 mg, 2.97 mmol) was dissolved in dry THF (15 mL) and cooled to -78 °C.  N-
butyllithium (2.5 N solution in hexanes, 1.2 mL) was added dropwise and allowed to stir 
for 30 mins at -78 °C. A solution of 2,6-difluoro benzyl bromide (615 mg, 2.97 mmol) in 
THF (1 mL) was added dropwise and allowed to stir for 2hrs at -78 °C. The reaction was 
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quenched with saturated NH4Cl, the organic separated and the aqueous layer extracted 3x 
with dichloromethane. The combined organic layers were washed with brine (3x) and 
dried over Na2SO4. The crude product was purified on a silica gel column with 4:1 
hexanes: EtOAc to yield a white solid. 1H-NMR (500 MHz, CDCl3) δ 0.66-0.64 (d, 3H), 
0.99-0.97 (d, 3H), 1.22-1.18 (t, 3H), 1.27-1.24 (t, 3H), 2.22-2.18 (m, 1H), 2.98-2.94 (m, 
1H), 3.25-3.21 (m, 1H), 3.61-3.59 (t, 1H), 4.18-3.97 (m, 4H), 4.25-4.21 (m, 1H), 6.83-
6.79 (dd, 2H), 7.15-7.12 (m, 1H) 
 
(S)-ethyl 2-amino-3-(2,6-difluorophenyl)propanoate (4). Compound 3 (268 mg, 0.792 
mmol) was dissolved in THF (19 mL) at 23 °C in a rb flask equipped with a magnetic stir 
bar and cooled to 0 °C. To this solution, 2N HCl (11 mL) was added and the solution 
allowed to stir for 10 mins at 10 °C while warming to 23 °C over 2 hrs. Ice was added to 
the mixture and the pH tuned with aqueous ammonia. The solution was extracted with 
dichloromethane (3x) and the combined organic layers washed with brine and dried over 
Na2SO4. The crude product was purified on a silica gel column with 1:1 EtOAc: hexanes 
to yield 4 as a white solid. 1H-NMR (500 MHz, CDCl3) δ 1.23-1.20 (t, 3H), 2.96-2.92 
(dd, 1H), 3.12-3.08 (dd, 1H), 3.73-3.71 (t, 1H), 4.17-4.13 (q, 2H), 6.87-6.83 (dd, 2H), 
7.19-7.15 (m, 1H) 
 
Fmoc-N-2,6-difluorophenylalanine (6).  Compound 4 (150 mg, 0.655 mmol) was 
dissolved in ethanol (3.3 mL) and added to a rb flask quipped with a stir bar. 1M NaOH 
(2.2 mL) was added and the resulting solution mixed at 50 °C for 2 hrs. The reaction was 
quenched with ice and the pH adjusted to 7 with 2N HCl. The resulting solution was 
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concentrated in vacuo and redissolved in 9% sodium carbonate (2.6 mL) and cooled to 0 
°C. Fmoc-Osu (220 mg, 0.652 mmol) was dissolved in acetonitrile (2 mL) and added to 
the solution. The mixture was left to stir for 1 h at room temperature. The solution was 
diluted with water and tuned to pH 2 with concentrated HCl. The organic phase was 
separated and the aqueous phase extracted with ethyl acetate (6x). The combined organic 
layers were washed with brine (2x) and water (2x) and concentrated in vacuo. The crude 
product was purified by silica gel chromatography 2:1 EtOAc: hexanes (2% acetic acid) 
to afford 6 as a white solid. 1H-NMR (500 MHz, CDCl3) δ 3.15-3.10 (dd, 1H), 3.29-3.27 
(dd, 1H), 4.12-4.03 (t, 1H), 4.26-4.14 (m, 2H), 4.49-4.46 (dd, 1H), 6.91-6.88 (t, 2H), 
7.24-7.22 (m, 1H), 7.31-7.25 (m, 2H), 7.39-7.36 (t, 2H), 7.61-7.59 (dd, 2H), 7.78-7.77 (d, 
2H) 
 
III. Peptide Synthesis and Characterization 
All peptides were synthesized via solid phase peptide synthesis (SPPS) using 
standard Fmoc/tBu chemistry. Syntheses were performed on a 0.05mmol scale using 
Fmoc-Phe-Wang resin and 5 equivalents of Fmoc-protected amino acids. The resin was 
treated twice with a mixture of 20% piperidine v/v in DMF for 10 mins each at room 
temperature. The subsequent Fmoc-protected amino acids coupled by activating the 
carboxylic acid with 0.05 mmol HBTU for 2.5 mins with 0.4 M N-methylmorpholine in 
DMF. After activation, amino acids were mixed with the resin for 30 mins at room 
temperature. A final Fmoc-deprotection step was incorporated on the terminal residue 
and the peptide was cleaved and globally deprotected with reagent K (80% TFA, 7.5% 
phenol, 5% thioanisole, 5% H2O and 2.5% 1,2,ethanedithiol) for 2 hrs at room 
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temperature. The crude products were precipitated with cold diethyl ether (3x), 
centrifuged and vacuum-dried overnight. 
 
Peptide sequence. All mutations were made at position F10. 
   6        10      17 
WT: H2N—LSDEDFKAVFGMTRSAFANLPLWKQQHLKKEKGLF--COOH 
 
Purification. Peptides were purified by reverse-phase HPLC on a Waters PrepLC using a 
Phenomenex Jupiter C18 prep column (250 x 20.00 mm, 10 micron). After purification, 
peptides pure fractions were collected, combined and lyophilized for further analysis. 
Purities and identities were confirmed using LC-MS analysis.  
 
IV. Circular Dichroism Spectroscopy 
All peptides samples for CD analysis were dissolved in Native Buffer A (20 mM 
NaPi. 150 mM NaCl, pH 7.4). Wavelength scans in the Far-UV region were collected 
using an AVIV model 202SF CD spectrometer equipped with a temperature-controlled 
cell holder. CD spectra were recorded at 2 °C using a 2 mm path length quartz cuvette 
and monitored at a wavelength between 260 nm to 190 nm. All HP35 variants displayed 
the characteristic α-helical structures with ellipticity minima at 222 nm and 208 nm. 
 
V. Thermal and Thermodynamic Analysis 
 Thermal denaturation experiments were monitored at a wavelength of 222 nm for 
all samples. Peptides samples were prepared in Native Buffer A (20 mM NaPi. 150 mM 
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NaCl, pH 7.4) at a concentration of 50 µM in a 2 mm path length quartz cuvette. The 
ellipticity data were collected at 2 °C increments with a 90 s equilibration time and 
signals were averaged for 30 s. All thermal denaturation curves display sigmoidal 
transitions, which were then tabulated to yield Tm values.  
 
Guanidinium chloride (Gdm·Cl) denaturation experiments were carried out at 2 °C on the 
circular dichroism spectrometer equipped with an automated titrator. Two 10 µM peptide 
solutions were prepared: solution A in Native Buffer A and solution B in Native Buffer B 
(20 mM NaPi. 150 mM NaCl, 7M Gdm·Cl, pH 7.4). 2.6 mL of solution A was added to a 
10 mm path length quartz cuvette equipped with a magnetic stir bar. Solution B was 
added in fractions and before each addition, an equal volume of the solution in the 
cuvette was taken out. After each addition, the sample was mixed for 30 seconds, 
followed by a 2 min equilibration period. The ellipticity values were recorded at 225 nm 
and plotted against concentration to yield the denaturation curves. Thermodynamic fitting 
using the standard baseline extrapolation method gave the thermodynamic parameters 
listed in Table 2. 
 
VI. Experimental LogP Calculations 
LogP values were measured using N-terminal acetylated amino acids. Briefly, 
Fmoc-protected unnatural amino acids were deprotected using 20% piperidine in DCM 
v/v solution for 30 mins. The solvent was removed in vacuo to isolate the free amino 
acids, which were then re-dissolved in methanol (3 mL), Et3N (2 equivalents) and acetic 
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anhydride (2 equivalents) and sonicated for 20 minutes at room temperature to yield the 
acetylated molecules.  
LogP experiments were performed by preparing a solution of the acetyl-protected 
amino acid (8 mg/mL) in a Gly buffer, pH 2.0 and adding an equal volume of octanol. 
The solution was vortexed and left to sit for 30 mins at room temperature. The layers 
were separated and analyzed by LC-MS to determine their UV absorption values. The 
LogP value was calculated by dividing the area under the curve of the octanol layer by 
the aqueous layer. The experiment was repeated to confirm reproducibility.     
 
VII. 19F NMR analysis. 
Samples for 1D 19F NMR experiments were prepared by dissolving the peptide in 
a 20 mM sodium phosphate buffer, pH 5.5, H2O:D2O (9:1) to a concentration of 1 mM. 
Temperature gradient measurements were taken on an INOVA 600 MHz NMR 
spectrometer and an echo experiment was performed for each peptide mutant to 
circumnavigate the TFA signal. NMR data were processed using MestRe Nova 
(Mestrelab Research S. L. Spain). 
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